Background  ||| S:24 E:43 ||| NN
The  ||| S:43 E:47 ||| DT
CD98  ||| S:47 E:52 ||| NNP
( ||| S:52 E:53 ||| -LRB-
4F2 ||| S:53 E:56 ||| NNP
,  ||| S:56 E:58 ||| ,
FRP-1 ||| S:58 E:63 ||| CD
)  ||| S:63 E:65 ||| -RRB-
molecule ||| S:65 E:73 ||| NN
,  ||| S:73 E:75 ||| ,
a  ||| S:75 E:77 ||| DT
cell  ||| S:77 E:82 ||| NN
surface  ||| S:82 E:98 ||| NN
disulfide-linked  ||| S:98 E:115 ||| JJ
heterodimer ||| S:115 E:126 ||| NN
,  ||| S:126 E:128 ||| ,
was  ||| S:128 E:132 ||| VBD
originally  ||| S:132 E:143 ||| RB
described  ||| S:143 E:153 ||| VBN
as  ||| S:153 E:156 ||| IN
a  ||| S:156 E:166 ||| DT
T  ||| S:166 E:168 ||| NN
cell  ||| S:168 E:173 ||| NN
activation  ||| S:173 E:184 ||| NN
antigen  ||| S:184 E:192 ||| NN
[  ||| S:192 E:194 ||| -LRB-
1  ||| S:194 E:196 ||| LS
]  ||| S:196 E:198 ||| -RRB-
,  ||| S:198 E:200 ||| ,
and  ||| S:200 E:204 ||| CC
later  ||| S:204 E:210 ||| RB
was  ||| S:210 E:214 ||| VBD
shown  ||| S:214 E:220 ||| VBN
to  ||| S:220 E:231 ||| TO
provide  ||| S:231 E:239 ||| VB
a  ||| S:239 E:241 ||| DT
co-stimulatory  ||| S:241 E:256 ||| JJ
signal  ||| S:256 E:263 ||| NN
for  ||| S:263 E:267 ||| IN
CD3-mediated  ||| S:267 E:280 ||| CD
T-cell  ||| S:280 E:295 ||| JJ
activation  ||| S:295 E:306 ||| NNS
[  ||| S:306 E:308 ||| -LRB-
2  ||| S:308 E:310 ||| LS
]  ||| S:310 E:312 ||| -RRB-
,  ||| S:312 E:314 ||| ,
independent  ||| S:314 E:326 ||| JJ
of  ||| S:326 E:329 ||| IN
CD28 ||| S:329 E:333 ||| FW
/ ||| S:333 E:334 ||| FW
CD80 ||| S:334 E:338 ||| FW
/ ||| S:338 E:339 ||| FW
CD86  ||| S:339 E:352 ||| FW
interaction  ||| S:352 E:364 ||| FW
[  ||| S:364 E:366 ||| -LRB-
3  ||| S:366 E:368 ||| LS
]  ||| S:368 E:370 ||| -RRB-
.  ||| S:370 E:372 ||| .
In  ||| S:372 E:375 ||| IN
other  ||| S:375 E:381 ||| JJ
studies ||| S:381 E:388 ||| NNS
,  ||| S:388 E:390 ||| ,
triggering  ||| S:390 E:401 ||| VBG
of  ||| S:401 E:404 ||| IN
human  ||| S:404 E:418 ||| JJ
monocyte  ||| S:418 E:427 ||| JJ
CD98  ||| S:427 E:432 ||| NN
could  ||| S:432 E:438 ||| MD
suppress  ||| S:438 E:447 ||| VB
T  ||| S:447 E:449 ||| NN
cell  ||| S:449 E:454 ||| NN
proliferation  ||| S:454 E:468 ||| NN
[  ||| S:468 E:470 ||| -LRB-
4  ||| S:470 E:472 ||| LS
]  ||| S:472 E:474 ||| -RRB-
,  ||| S:474 E:484 ||| ,
or  ||| S:484 E:487 ||| CC
promote  ||| S:487 E:495 ||| VB
homotypic  ||| S:495 E:505 ||| JJ
cell  ||| S:505 E:510 ||| NN
aggregation  ||| S:510 E:522 ||| NN
of  ||| S:522 E:525 ||| IN
monocytes  ||| S:525 E:535 ||| NNS
[  ||| S:535 E:537 ||| -LRB-
5  ||| S:537 E:539 ||| LS
]  ||| S:539 E:541 ||| -RRB-
.  ||| S:541 E:551 ||| .
Also ||| S:551 E:555 ||| RB
,  ||| S:555 E:557 ||| ,
CD98  ||| S:557 E:562 ||| NNP
may  ||| S:562 E:566 ||| MD
be  ||| S:566 E:569 ||| VB
a  ||| S:569 E:571 ||| DT
target  ||| S:571 E:578 ||| NN
antigen  ||| S:578 E:586 ||| NN
for  ||| S:586 E:590 ||| IN
natural  ||| S:590 E:598 ||| JJ
killer  ||| S:598 E:605 ||| NN
cells  ||| S:605 E:619 ||| NNS
[  ||| S:619 E:621 ||| -LRB-
6  ||| S:621 E:623 ||| CD
]  ||| S:623 E:625 ||| -RRB-
,  ||| S:625 E:627 ||| ,
may  ||| S:627 E:631 ||| MD
mediate  ||| S:631 E:639 ||| VB
fusion  ||| S:639 E:646 ||| NN
of  ||| S:646 E:649 ||| IN
blood  ||| S:649 E:655 ||| NN
monocytes  ||| S:655 E:665 ||| VBZ
leading  ||| S:665 E:673 ||| VBG
to  ||| S:673 E:684 ||| TO
osteoclast  ||| S:684 E:695 ||| VB
formation  ||| S:695 E:705 ||| NN
[  ||| S:705 E:707 ||| -LRB-
7  ||| S:707 E:709 ||| CD
8  ||| S:709 E:711 ||| CD
]  ||| S:711 E:713 ||| -RRB-
,  ||| S:713 E:715 ||| ,
and  ||| S:715 E:719 ||| CC
may  ||| S:719 E:723 ||| MD
modulate  ||| S:723 E:740 ||| VB
hematopoietic  ||| S:740 E:754 ||| JJ
cell  ||| S:754 E:759 ||| NN
survival  ||| S:759 E:768 ||| NN
and  ||| S:768 E:772 ||| CC
differentiation  ||| S:772 E:788 ||| NNS
[  ||| S:788 E:790 ||| -LRB-
9  ||| S:790 E:792 ||| CD
]  ||| S:792 E:794 ||| -RRB-
.  ||| S:794 E:804 ||| .
The  ||| S:804 E:808 ||| DT
CD98  ||| S:808 E:813 ||| JJ
molecule  ||| S:813 E:822 ||| NN
is  ||| S:822 E:825 ||| VBZ
also  ||| S:825 E:830 ||| RB
widely  ||| S:830 E:837 ||| RB
expressed  ||| S:837 E:847 ||| VBN
on  ||| S:847 E:850 ||| IN
rapidly  ||| S:850 E:866 ||| RB
growing  ||| S:866 E:874 ||| VBG
non-hematopoietic  ||| S:874 E:892 ||| JJ
cells ||| S:892 E:897 ||| NNS
,  ||| S:897 E:899 ||| ,
where  ||| S:899 E:905 ||| WRB
it  ||| S:905 E:908 ||| PRP
may  ||| S:908 E:912 ||| MD
modulate  ||| S:912 E:929 ||| VB
oncogenic  ||| S:929 E:939 ||| JJ
transformation  ||| S:939 E:954 ||| NN
[  ||| S:954 E:956 ||| -LRB-
10  ||| S:956 E:959 ||| CD
11  ||| S:959 E:962 ||| CD
]  ||| S:962 E:964 ||| -RRB-
,  ||| S:964 E:966 ||| ,
metal  ||| S:966 E:972 ||| NN
ion  ||| S:972 E:976 ||| NN
transport  ||| S:976 E:986 ||| NN
[  ||| S:986 E:996 ||| -LRB-
12  ||| S:996 E:999 ||| CD
13  ||| S:999 E:1002 ||| CD
]  ||| S:1002 E:1004 ||| -RRB-
,  ||| S:1004 E:1006 ||| ,
cell  ||| S:1006 E:1011 ||| NN
fusion  ||| S:1011 E:1018 ||| NN
[  ||| S:1018 E:1020 ||| -LRB-
14  ||| S:1020 E:1023 ||| CD
15  ||| S:1023 E:1026 ||| CD
]  ||| S:1026 E:1028 ||| -RRB-
,  ||| S:1028 E:1030 ||| ,
and  ||| S:1030 E:1034 ||| CC
amino  ||| S:1034 E:1040 ||| JJ
acid  ||| S:1040 E:1045 ||| NN
transport  ||| S:1045 E:1063 ||| NN
[  ||| S:1063 E:1065 ||| -LRB-
16  ||| S:1065 E:1068 ||| CD
17  ||| S:1068 E:1071 ||| CD
18  ||| S:1071 E:1074 ||| CD
19  ||| S:1074 E:1077 ||| CD
]  ||| S:1077 E:1079 ||| -RRB-
.  ||| S:1079 E:1081 ||| .
CD98  ||| S:1081 E:1086 ||| NNP
is  ||| S:1086 E:1089 ||| VBZ
also  ||| S:1089 E:1094 ||| RB
expressed  ||| S:1094 E:1104 ||| VBN
on  ||| S:1104 E:1107 ||| IN
normal  ||| S:1107 E:1122 ||| JJ
proliferating  ||| S:1122 E:1136 ||| JJ
tissue  ||| S:1136 E:1143 ||| NN
such  ||| S:1143 E:1148 ||| JJ
as  ||| S:1148 E:1151 ||| IN
the  ||| S:1151 E:1155 ||| DT
basal  ||| S:1155 E:1161 ||| JJ
layer  ||| S:1161 E:1167 ||| NN
of  ||| S:1167 E:1170 ||| IN
squamous  ||| S:1170 E:1187 ||| JJ
epithelia  ||| S:1187 E:1197 ||| NNS
[  ||| S:1197 E:1199 ||| -LRB-
20  ||| S:1199 E:1202 ||| CD
]  ||| S:1202 E:1204 ||| -RRB-
and  ||| S:1204 E:1208 ||| CC
on  ||| S:1208 E:1211 ||| IN
cells  ||| S:1211 E:1217 ||| NNS
having  ||| S:1217 E:1224 ||| VBG
secretion  ||| S:1224 E:1234 ||| NNS
or  ||| S:1234 E:1237 ||| CC
transport  ||| S:1237 E:1255 ||| NN
functions  ||| S:1255 E:1265 ||| NNS
[  ||| S:1265 E:1267 ||| -LRB-
21  ||| S:1267 E:1270 ||| CD
]  ||| S:1270 E:1272 ||| -RRB-
.  ||| S:1272 E:1274 ||| .
Understanding  ||| S:1274 E:1288 ||| NN
of  ||| S:1288 E:1291 ||| IN
the  ||| S:1291 E:1295 ||| DT
role  ||| S:1295 E:1300 ||| NN
of  ||| S:1300 E:1303 ||| IN
CD98  ||| S:1303 E:1308 ||| CD
in  ||| S:1308 E:1319 ||| IN
amino  ||| S:1319 E:1325 ||| JJ
acid  ||| S:1325 E:1330 ||| NN
transport  ||| S:1330 E:1340 ||| NN
has  ||| S:1340 E:1344 ||| VBZ
been  ||| S:1344 E:1349 ||| VBN
greatly  ||| S:1349 E:1357 ||| RB
enhanced  ||| S:1357 E:1366 ||| VBN
with  ||| S:1366 E:1371 ||| IN
the  ||| S:1371 E:1383 ||| DT
recent  ||| S:1383 E:1390 ||| JJ
cloning  ||| S:1390 E:1398 ||| NN
and  ||| S:1398 E:1402 ||| CC
characterization  ||| S:1402 E:1419 ||| NN
of  ||| S:1419 E:1422 ||| IN
multiple  ||| S:1422 E:1431 ||| JJ
CD98  ||| S:1431 E:1436 ||| CD
light  ||| S:1436 E:1450 ||| JJ
chains ||| S:1450 E:1456 ||| NNS
.  ||| S:1456 E:1458 ||| .
Distinct  ||| S:1458 E:1467 ||| JJ
CD98  ||| S:1467 E:1472 ||| CD
light  ||| S:1472 E:1478 ||| JJ
chains  ||| S:1478 E:1485 ||| NNS
appear  ||| S:1485 E:1492 ||| VBP
to  ||| S:1492 E:1495 ||| TO
mediate  ||| S:1495 E:1511 ||| VB
distinct  ||| S:1511 E:1520 ||| JJ
amino  ||| S:1520 E:1526 ||| JJ
acid  ||| S:1526 E:1531 ||| NN
transport  ||| S:1531 E:1541 ||| NN
activities  ||| S:1541 E:1552 ||| NNS
( ||| S:1552 E:1553 ||| -LRB-
for  ||| S:1553 E:1557 ||| IN
review  ||| S:1557 E:1564 ||| NN
see  ||| S:1564 E:1568 ||| VBP
[  ||| S:1568 E:1578 ||| -LRB-
22  ||| S:1578 E:1581 ||| CD
23  ||| S:1581 E:1584 ||| CD
]  ||| S:1584 E:1586 ||| CD
) ||| S:1586 E:1587 ||| -RRB-
.  ||| S:1587 E:1597 ||| .
Several  ||| S:1597 E:1605 ||| JJ
lines  ||| S:1605 E:1611 ||| NNS
of  ||| S:1611 E:1614 ||| IN
evidence  ||| S:1614 E:1623 ||| NN
now  ||| S:1623 E:1627 ||| RB
suggest  ||| S:1627 E:1635 ||| VB
that  ||| S:1635 E:1640 ||| IN
CD98  ||| S:1640 E:1645 ||| NNP
may  ||| S:1645 E:1657 ||| MD
modulate  ||| S:1657 E:1666 ||| VB
the  ||| S:1666 E:1670 ||| DT
functions  ||| S:1670 E:1680 ||| NNS
of  ||| S:1680 E:1683 ||| IN
integrins ||| S:1683 E:1692 ||| NN
.  ||| S:1692 E:1694 ||| .
For  ||| S:1694 E:1698 ||| IN
example ||| S:1698 E:1705 ||| NN
,  ||| S:1705 E:1707 ||| ,
CD98  ||| S:1707 E:1712 ||| NNP
and  ||| S:1712 E:1724 ||| CC
β1  ||| S:1724 E:1727 ||| CD
integrins  ||| S:1727 E:1737 ||| NNS
may  ||| S:1737 E:1741 ||| MD
act  ||| S:1741 E:1745 ||| VB
together  ||| S:1745 E:1754 ||| RP
during  ||| S:1754 E:1761 ||| IN
T-cell  ||| S:1761 E:1768 ||| JJ
co-stimulation  ||| S:1768 E:1791 ||| NN
[  ||| S:1791 E:1793 ||| -LRB-
24  ||| S:1793 E:1796 ||| CD
]  ||| S:1796 E:1798 ||| -RRB-
.  ||| S:1798 E:1800 ||| .
A  ||| S:1800 E:1802 ||| DT
genetic  ||| S:1802 E:1810 ||| JJ
screen  ||| S:1810 E:1817 ||| NN
revealed  ||| S:1817 E:1826 ||| VBD
that  ||| S:1826 E:1831 ||| IN
CD98  ||| S:1831 E:1836 ||| NNP
may  ||| S:1836 E:1840 ||| MD
indirectly  ||| S:1840 E:1859 ||| RB
influence  ||| S:1859 E:1869 ||| VB
integrin  ||| S:1869 E:1878 ||| JJ
affinity  ||| S:1878 E:1887 ||| NN
for  ||| S:1887 E:1891 ||| IN
ligand  ||| S:1891 E:1898 ||| NNS
[  ||| S:1898 E:1900 ||| -LRB-
25  ||| S:1900 E:1903 ||| CD
]  ||| S:1903 E:1905 ||| -RRB-
.  ||| S:1905 E:1907 ||| .
Also ||| S:1907 E:1911 ||| RB
,  ||| S:1911 E:1921 ||| ,
anti-CD98  ||| S:1921 E:1931 ||| NNP
mAb  ||| S:1931 E:1935 ||| NNP
appeared  ||| S:1935 E:1944 ||| VBD
to  ||| S:1944 E:1947 ||| TO
modulate  ||| S:1947 E:1956 ||| VB
integrin-dependent  ||| S:1956 E:1983 ||| JJ
adhesion  ||| S:1983 E:1992 ||| NN
in  ||| S:1992 E:1995 ||| IN
two  ||| S:1995 E:1999 ||| CD
separate  ||| S:1999 E:2008 ||| JJ
studies  ||| S:2008 E:2016 ||| NNS
[  ||| S:2016 E:2018 ||| -LRB-
25  ||| S:2018 E:2021 ||| CD
26  ||| S:2021 E:2024 ||| CD
]  ||| S:2024 E:2026 ||| -RRB-
.  ||| S:2026 E:2028 ||| .
In  ||| S:2028 E:2031 ||| IN
addition ||| S:2031 E:2039 ||| NN
,  ||| S:2039 E:2049 ||| ,
antibodies  ||| S:2049 E:2060 ||| NNS
to  ||| S:2060 E:2063 ||| TO
both  ||| S:2063 E:2068 ||| DT
CD98  ||| S:2068 E:2073 ||| NNP
and  ||| S:2073 E:2077 ||| CC
α3β1  ||| S:2077 E:2082 ||| NNP
integrin  ||| S:2082 E:2091 ||| VBD
promoted  ||| S:2091 E:2100 ||| VBN
cell  ||| S:2100 E:2113 ||| NN
fusion  ||| S:2113 E:2120 ||| NN
[  ||| S:2120 E:2122 ||| -LRB-
27  ||| S:2122 E:2125 ||| CD
]  ||| S:2125 E:2127 ||| -RRB-
,  ||| S:2127 E:2129 ||| ,
and  ||| S:2129 E:2133 ||| CC
antibodies  ||| S:2133 E:2144 ||| NNS
to  ||| S:2144 E:2147 ||| TO
β1  ||| S:2147 E:2150 ||| CD
and  ||| S:2150 E:2154 ||| CC
β2  ||| S:2154 E:2157 ||| CD
integrins  ||| S:2157 E:2175 ||| NNS
blocked  ||| S:2175 E:2183 ||| VBD
monocyte  ||| S:2183 E:2192 ||| JJ
cell-cell  ||| S:2192 E:2202 ||| JJ
fusion  ||| S:2202 E:2209 ||| NN
and  ||| S:2209 E:2213 ||| CC
aggregation  ||| S:2213 E:2225 ||| JJ
functions  ||| S:2225 E:2243 ||| NNS
induced  ||| S:2243 E:2251 ||| VBN
by  ||| S:2251 E:2254 ||| IN
an  ||| S:2254 E:2257 ||| DT
anti-CD98  ||| S:2257 E:2267 ||| NNP
mAb  ||| S:2267 E:2271 ||| NNP
[  ||| S:2271 E:2273 ||| -LRB-
5  ||| S:2273 E:2275 ||| LS
]  ||| S:2275 E:2277 ||| -RRB-
.  ||| S:2277 E:2279 ||| .
Finally ||| S:2279 E:2286 ||| RB
,  ||| S:2286 E:2288 ||| ,
like  ||| S:2288 E:2293 ||| IN
CD98 ||| S:2293 E:2297 ||| NNP
,  ||| S:2297 E:2299 ||| ,
the  ||| S:2299 E:2311 ||| DT
α3β1  ||| S:2311 E:2316 ||| JJ
integrin  ||| S:2316 E:2325 ||| NN
has  ||| S:2325 E:2329 ||| VBZ
been  ||| S:2329 E:2334 ||| VBN
implicated  ||| S:2334 E:2345 ||| VBN
in  ||| S:2345 E:2348 ||| IN
amino  ||| S:2348 E:2354 ||| JJ
acid  ||| S:2354 E:2359 ||| NN
transport  ||| S:2359 E:2369 ||| NN
[  ||| S:2369 E:2379 ||| -LRB-
28  ||| S:2379 E:2382 ||| CD
]  ||| S:2382 E:2384 ||| -RRB-
.  ||| S:2384 E:2394 ||| .
The  ||| S:2394 E:2398 ||| DT
biochemical  ||| S:2398 E:2410 ||| JJ
mechanism  ||| S:2410 E:2420 ||| NN
by  ||| S:2420 E:2423 ||| IN
which  ||| S:2423 E:2429 ||| WDT
CD98  ||| S:2429 E:2434 ||| NNP
and  ||| S:2434 E:2438 ||| CC
integrins  ||| S:2438 E:2456 ||| JJ
functionally  ||| S:2456 E:2469 ||| JJ
interact  ||| S:2469 E:2478 ||| NN
remains  ||| S:2478 E:2486 ||| VBZ
unclear ||| S:2486 E:2493 ||| JJ
.  ||| S:2493 E:2495 ||| .
The  ||| S:2495 E:2499 ||| DT
CD98  ||| S:2499 E:2504 ||| JJ
molecule  ||| S:2504 E:2521 ||| NN
associates  ||| S:2521 E:2532 ||| NNS
specifically  ||| S:2532 E:2545 ||| RB
with  ||| S:2545 E:2550 ||| IN
immobilized  ||| S:2550 E:2562 ||| FW
β1  ||| S:2562 E:2565 ||| FW
integrin  ||| S:2565 E:2582 ||| FW
cytoplasmic  ||| S:2582 E:2594 ||| FW
tail  ||| S:2594 E:2599 ||| FW
fusion  ||| S:2599 E:2606 ||| NN
proteins  ||| S:2606 E:2615 ||| NNS
under  ||| S:2615 E:2621 ||| IN
very  ||| S:2621 E:2626 ||| RB
mild  ||| S:2626 E:2631 ||| JJ
detergent  ||| S:2631 E:2649 ||| NN
conditions  ||| S:2649 E:2660 ||| NNS
( ||| S:2660 E:2661 ||| -LRB-
0.05 ||| S:2661 E:2665 ||| CD
%  ||| S:2665 E:2667 ||| NN
Triton  ||| S:2667 E:2674 ||| NNP
X-100 ||| S:2674 E:2679 ||| NNP
)  ||| S:2679 E:2681 ||| -RRB-
[  ||| S:2681 E:2683 ||| -LRB-
29  ||| S:2683 E:2686 ||| CD
]  ||| S:2686 E:2688 ||| -RRB-
,  ||| S:2688 E:2690 ||| ,
but  ||| S:2690 E:2694 ||| CC
CD98  ||| S:2694 E:2699 ||| NNP
has  ||| S:2699 E:2703 ||| VBZ
not  ||| S:2703 E:2715 ||| RB
yet  ||| S:2715 E:2719 ||| RB
been  ||| S:2719 E:2724 ||| VBN
shown  ||| S:2724 E:2730 ||| VBN
to  ||| S:2730 E:2733 ||| TO
interact  ||| S:2733 E:2742 ||| VB
physically  ||| S:2742 E:2753 ||| RB
with  ||| S:2753 E:2758 ||| IN
intact  ||| S:2758 E:2765 ||| JJ
β1  ||| S:2765 E:2776 ||| CD
integrins ||| S:2776 E:2785 ||| NNS
.  ||| S:2785 E:2787 ||| .
We  ||| S:2787 E:2790 ||| PRP
began  ||| S:2790 E:2796 ||| VBD
the  ||| S:2796 E:2800 ||| DT
present  ||| S:2800 E:2808 ||| JJ
study  ||| S:2808 E:2814 ||| NN
by  ||| S:2814 E:2817 ||| IN
searching  ||| S:2817 E:2827 ||| VBG
for  ||| S:2827 E:2839 ||| IN
integrin-associated  ||| S:2839 E:2859 ||| JJ
proteins  ||| S:2859 E:2868 ||| NNS
in  ||| S:2868 E:2871 ||| IN
an  ||| S:2871 E:2874 ||| DT
unbiased  ||| S:2874 E:2883 ||| JJ
manner  ||| S:2883 E:2890 ||| NN
( ||| S:2890 E:2891 ||| -LRB-
i.e.  ||| S:2891 E:2896 ||| FW
we  ||| S:2896 E:2907 ||| PRP
were  ||| S:2907 E:2912 ||| VBD
not  ||| S:2912 E:2916 ||| RB
specifically  ||| S:2916 E:2929 ||| RB
looking  ||| S:2929 E:2937 ||| VBG
for  ||| S:2937 E:2941 ||| IN
CD98 ||| S:2941 E:2945 ||| CD
) ||| S:2945 E:2946 ||| -RRB-
.  ||| S:2946 E:2948 ||| .
We  ||| S:2948 E:2951 ||| PRP
utilized  ||| S:2951 E:2960 ||| VBD
a  ||| S:2960 E:2970 ||| DT
monoclonal  ||| S:2970 E:2981 ||| JJ
antibody  ||| S:2981 E:2990 ||| NN
screening  ||| S:2990 E:3000 ||| NN
method  ||| S:3000 E:3007 ||| NN
involving  ||| S:3007 E:3025 ||| VBG
co-immunoprecipitation  ||| S:3025 E:3048 ||| JJ
of  ||| S:3048 E:3051 ||| IN
integrins  ||| S:3051 E:3061 ||| NN
under  ||| S:3061 E:3067 ||| IN
non-stringent  ||| S:3067 E:3089 ||| JJ
detergent  ||| S:3089 E:3099 ||| NN
conditions  ||| S:3099 E:3110 ||| NNS
[  ||| S:3110 E:3112 ||| -LRB-
30  ||| S:3112 E:3115 ||| CD
31  ||| S:3115 E:3118 ||| CD
]  ||| S:3118 E:3120 ||| -RRB-
.  ||| S:3120 E:3122 ||| .
Using  ||| S:3122 E:3128 ||| VBG
this  ||| S:3128 E:3133 ||| DT
approach ||| S:3133 E:3141 ||| NN
,  ||| S:3141 E:3143 ||| ,
we  ||| S:3143 E:3154 ||| PRP
have  ||| S:3154 E:3159 ||| VBP
previously  ||| S:3159 E:3170 ||| RB
discovered  ||| S:3170 E:3181 ||| VBN
specific  ||| S:3181 E:3190 ||| JJ
associations  ||| S:3190 E:3203 ||| NNS
between  ||| S:3203 E:3219 ||| IN
particular  ||| S:3219 E:3230 ||| JJ
β1  ||| S:3230 E:3233 ||| CD
integrins  ||| S:3233 E:3243 ||| NNS
and  ||| S:3243 E:3247 ||| CC
other  ||| S:3247 E:3253 ||| JJ
cell  ||| S:3253 E:3258 ||| NN
surface  ||| S:3258 E:3266 ||| NN
molecules  ||| S:3266 E:3284 ||| NNS
including  ||| S:3284 E:3294 ||| VBG
CD147 ||| S:3294 E:3299 ||| NNP
/ ||| S:3299 E:3300 ||| NNP
EMMPRIN  ||| S:3300 E:3308 ||| NNP
[  ||| S:3308 E:3310 ||| -LRB-
31  ||| S:3310 E:3313 ||| CD
]  ||| S:3313 E:3315 ||| -RRB-
,  ||| S:3315 E:3317 ||| ,
and  ||| S:3317 E:3321 ||| CC
various  ||| S:3321 E:3329 ||| JJ
tetraspanin  ||| S:3329 E:3349 ||| NNS
( ||| S:3349 E:3350 ||| -LRB-
transmembrane-4  ||| S:3350 E:3366 ||| FW
superfamily ||| S:3366 E:3377 ||| FW
)  ||| S:3377 E:3379 ||| -RRB-
proteins  ||| S:3379 E:3388 ||| NNS
[  ||| S:3388 E:3390 ||| -LRB-
30  ||| S:3390 E:3393 ||| CD
32  ||| S:3393 E:3396 ||| CD
33  ||| S:3396 E:3399 ||| CD
]  ||| S:3399 E:3401 ||| -RRB-
.  ||| S:3401 E:3403 ||| .
In  ||| S:3403 E:3414 ||| IN
this  ||| S:3414 E:3419 ||| DT
report  ||| S:3419 E:3426 ||| NN
we  ||| S:3426 E:3429 ||| PRP
demonstrate  ||| S:3429 E:3441 ||| VBP
for  ||| S:3441 E:3445 ||| IN
the  ||| S:3445 E:3449 ||| DT
first  ||| S:3449 E:3455 ||| JJ
time  ||| S:3455 E:3460 ||| NN
that  ||| S:3460 E:3465 ||| IN
CD98  ||| S:3465 E:3478 ||| CD
constitutively  ||| S:3478 E:3493 ||| NNS
and  ||| S:3493 E:3497 ||| CC
specifically  ||| S:3497 E:3510 ||| JJ
associates  ||| S:3510 E:3521 ||| NNS
with  ||| S:3521 E:3526 ||| IN
intact  ||| S:3526 E:3533 ||| FW
β1  ||| S:3533 E:3544 ||| FW
integrin  ||| S:3544 E:3553 ||| FW
heterodimers ||| S:3553 E:3565 ||| FW
.  ||| S:3565 E:3567 ||| .
Specific  ||| S:3567 E:3576 ||| JJ
CD98-integrin  ||| S:3576 E:3590 ||| CD
interaction  ||| S:3590 E:3610 ||| NN
occurs  ||| S:3610 E:3617 ||| VBZ
in  ||| S:3617 E:3620 ||| IN
the  ||| S:3620 E:3624 ||| DT
context  ||| S:3624 E:3632 ||| NN
of  ||| S:3632 E:3635 ||| IN
low  ||| S:3635 E:3639 ||| JJ
density  ||| S:3639 E:3647 ||| JJ
protein-lipid  ||| S:3647 E:3669 ||| JJ
microdomains ||| S:3669 E:3681 ||| NN
,  ||| S:3681 E:3683 ||| ,
possibly  ||| S:3683 E:3692 ||| RB
resembling  ||| S:3692 E:3703 ||| VBG
lipid  ||| S:3703 E:3709 ||| JJ
rafts  ||| S:3709 E:3715 ||| NNS
[  ||| S:3715 E:3717 ||| -LRB-
34  ||| S:3717 E:3720 ||| CD
35  ||| S:3720 E:3723 ||| CD
]  ||| S:3723 E:3725 ||| -RRB-
.  ||| S:3725 E:3735 ||| .
Several  ||| S:3735 E:3743 ||| JJ
important  ||| S:3743 E:3753 ||| JJ
signaling  ||| S:3753 E:3763 ||| JJ
molecules ||| S:3763 E:3772 ||| NNS
,  ||| S:3772 E:3774 ||| ,
including  ||| S:3774 E:3784 ||| VBG
activated  ||| S:3784 E:3802 ||| VBN
TCR ||| S:3802 E:3805 ||| NNP
,  ||| S:3805 E:3807 ||| ,
LAT  ||| S:3807 E:3811 ||| NNP
and  ||| S:3811 E:3815 ||| CC
LCK  ||| S:3815 E:3819 ||| NNP
are  ||| S:3819 E:3823 ||| VBP
present  ||| S:3823 E:3831 ||| JJ
in  ||| S:3831 E:3834 ||| IN
organized  ||| S:3834 E:3844 ||| JJ
raft-type  ||| S:3844 E:3862 ||| JJ
microdomains ||| S:3862 E:3874 ||| NN
,  ||| S:3874 E:3876 ||| ,
and  ||| S:3876 E:3880 ||| CC
integrity  ||| S:3880 E:3890 ||| NN
of  ||| S:3890 E:3893 ||| IN
these  ||| S:3893 E:3899 ||| DT
microdomains  ||| S:3899 E:3912 ||| NN
is  ||| S:3912 E:3923 ||| VBZ
necessary  ||| S:3923 E:3933 ||| JJ
for  ||| S:3933 E:3937 ||| IN
T  ||| S:3937 E:3939 ||| NN
cell  ||| S:3939 E:3944 ||| NN
receptor  ||| S:3944 E:3953 ||| NN
signal  ||| S:3953 E:3960 ||| NN
transduction  ||| S:3960 E:3973 ||| NNS
[  ||| S:3973 E:3975 ||| -LRB-
36  ||| S:3975 E:3978 ||| CD
37  ||| S:3978 E:3981 ||| CD
]  ||| S:3981 E:3991 ||| -RRB-
.  ||| S:3991 E:3993 ||| .
Our  ||| S:3993 E:3997 ||| PRP$
present  ||| S:3997 E:4005 ||| JJ
discovery  ||| S:4005 E:4015 ||| NN
that  ||| S:4015 E:4020 ||| IN
β1  ||| S:4020 E:4023 ||| CD
integrins  ||| S:4023 E:4033 ||| NNS
specifically  ||| S:4033 E:4054 ||| RB
associate  ||| S:4054 E:4064 ||| JJ
with  ||| S:4064 E:4069 ||| IN
CD98  ||| S:4069 E:4074 ||| CD
in  ||| S:4074 E:4077 ||| IN
lipid  ||| S:4077 E:4083 ||| JJ
microdomains  ||| S:4083 E:4096 ||| NN
helps  ||| S:4096 E:4102 ||| VBZ
to  ||| S:4102 E:4105 ||| TO
explain  ||| S:4105 E:4121 ||| VB
the  ||| S:4121 E:4125 ||| DT
functional  ||| S:4125 E:4136 ||| JJ
connections  ||| S:4136 E:4148 ||| NNS
between  ||| S:4148 E:4156 ||| IN
β1  ||| S:4156 E:4159 ||| CD
integrins  ||| S:4159 E:4169 ||| NNS
and  ||| S:4169 E:4173 ||| CC
CD98  ||| S:4173 E:4186 ||| CD
during  ||| S:4186 E:4193 ||| IN
T  ||| S:4193 E:4195 ||| NN
cell  ||| S:4195 E:4200 ||| NN
costimulation ||| S:4200 E:4213 ||| NN
,  ||| S:4213 E:4215 ||| ,
monocyte  ||| S:4215 E:4224 ||| JJ
fusion ||| S:4224 E:4230 ||| NN
,  ||| S:4230 E:4232 ||| ,
and  ||| S:4232 E:4244 ||| CC
elsewhere ||| S:4244 E:4253 ||| RB
.  ||| S:4253 E:4277 ||| .
Results  ||| S:4277 E:4285 ||| NNS
and  ||| S:4285 E:4289 ||| CC
Discussion  ||| S:4289 E:4319 ||| NNP
Identification  ||| S:4319 E:4334 ||| NNP
of  ||| S:4334 E:4337 ||| IN
CD98  ||| S:4337 E:4342 ||| CD
as  ||| S:4342 E:4345 ||| IN
a  ||| S:4345 E:4347 ||| DT
β1  ||| S:4347 E:4350 ||| JJ
integrin-associated  ||| S:4350 E:4380 ||| JJ
protein  ||| S:4380 E:4398 ||| NN
Mice  ||| S:4398 E:4403 ||| NNS
were  ||| S:4403 E:4408 ||| VBD
immunized  ||| S:4408 E:4418 ||| VBN
with  ||| S:4418 E:4423 ||| IN
MTSV1-7  ||| S:4423 E:4431 ||| CD
human  ||| S:4431 E:4437 ||| JJ
mammary  ||| S:4437 E:4455 ||| JJ
epithelial  ||| S:4455 E:4466 ||| JJ
cells ||| S:4466 E:4471 ||| NNS
,  ||| S:4471 E:4473 ||| ,
and  ||| S:4473 E:4477 ||| CC
approximately  ||| S:4477 E:4491 ||| RB
600  ||| S:4491 E:4495 ||| CD
hybridomas  ||| S:4495 E:4506 ||| NNS
were  ||| S:4506 E:4521 ||| VBD
generated ||| S:4521 E:4530 ||| VBN
.  ||| S:4530 E:4532 ||| .
Upon  ||| S:4532 E:4537 ||| IN
monoclonal  ||| S:4537 E:4548 ||| JJ
antibody  ||| S:4548 E:4557 ||| NN
screening ||| S:4557 E:4566 ||| NN
,  ||| S:4566 E:4568 ||| ,
16  ||| S:4568 E:4571 ||| CD
were  ||| S:4571 E:4586 ||| VBD
identified  ||| S:4586 E:4597 ||| VBN
that  ||| S:4597 E:4602 ||| IN
co-immunoprecipitated  ||| S:4602 E:4624 ||| JJ
integrins  ||| S:4624 E:4634 ||| NN
without  ||| S:4634 E:4652 ||| IN
recognizing  ||| S:4652 E:4664 ||| VBG
integrins  ||| S:4664 E:4674 ||| NNS
directly ||| S:4674 E:4682 ||| RB
.  ||| S:4682 E:4684 ||| .
Of  ||| S:4684 E:4687 ||| IN
these ||| S:4687 E:4692 ||| DT
,  ||| S:4692 E:4694 ||| ,
one  ||| S:4694 E:4698 ||| PRP
recognized  ||| S:4698 E:4719 ||| VBD
CD63  ||| S:4719 E:4724 ||| RB
as  ||| S:4724 E:4727 ||| RB
reported  ||| S:4727 E:4736 ||| VBD
previously  ||| S:4736 E:4747 ||| RB
[  ||| S:4747 E:4749 ||| -LRB-
30  ||| S:4749 E:4752 ||| CD
]  ||| S:4752 E:4754 ||| -RRB-
,  ||| S:4754 E:4756 ||| ,
and  ||| S:4756 E:4760 ||| CC
three  ||| S:4760 E:4766 ||| CD
( ||| S:4766 E:4767 ||| -LRB-
including  ||| S:4767 E:4787 ||| VBG
mAb  ||| S:4787 E:4791 ||| JJ
6B12 ||| S:4791 E:4795 ||| CD
)  ||| S:4795 E:4797 ||| -RRB-
recognized  ||| S:4797 E:4808 ||| VBD
a  ||| S:4808 E:4810 ||| DT
disulfide-linked  ||| S:4810 E:4827 ||| JJ
cell  ||| S:4827 E:4832 ||| NN
surface  ||| S:4832 E:4850 ||| NN
heterodimer  ||| S:4850 E:4862 ||| VBZ
consisting  ||| S:4862 E:4873 ||| VBG
of  ||| S:4873 E:4876 ||| IN
an  ||| S:4876 E:4879 ||| DT
85  ||| S:4879 E:4882 ||| CD
kD  ||| S:4882 E:4885 ||| JJ
heavy  ||| S:4885 E:4891 ||| JJ
chain  ||| S:4891 E:4897 ||| NN
and  ||| S:4897 E:4901 ||| CC
a  ||| S:4901 E:4903 ||| DT
35  ||| S:4903 E:4916 ||| CD
kD  ||| S:4916 E:4919 ||| JJ
light  ||| S:4919 E:4925 ||| JJ
chain ||| S:4925 E:4930 ||| NN
.  ||| S:4930 E:4942 ||| .
From  ||| S:4942 E:4947 ||| IN
I  ||| S:4947 E:4949 ||| PRP
125surface-labeled  ||| S:4949 E:4968 ||| VBZ
HT1080  ||| S:4968 E:4975 ||| CD
cells ||| S:4975 E:4980 ||| NNS
,  ||| S:4980 E:4982 ||| ,
mAb  ||| S:4982 E:4986 ||| NNP
6B12  ||| S:4986 E:5001 ||| NNP
immunoprecipitated  ||| S:5001 E:5020 ||| VBD
a  ||| S:5020 E:5022 ||| DT
heterodimer  ||| S:5022 E:5034 ||| NN
of  ||| S:5034 E:5037 ||| IN
85  ||| S:5037 E:5040 ||| CD
and  ||| S:5040 E:5044 ||| CC
35  ||| S:5044 E:5047 ||| CD
kD  ||| S:5047 E:5050 ||| NN
under  ||| S:5050 E:5066 ||| IN
reducing  ||| S:5066 E:5075 ||| VBG
conditions  ||| S:5075 E:5086 ||| NNS
( ||| S:5086 E:5087 ||| -LRB-
Fig.  ||| S:5087 E:5092 ||| CD
1 ||| S:5092 E:5093 ||| CD
,  ||| S:5093 E:5095 ||| ,
lane  ||| S:5095 E:5100 ||| VBG
a ||| S:5100 E:5101 ||| DT
,  ||| S:5101 E:5103 ||| ,
solid  ||| S:5103 E:5109 ||| JJ
arrows ||| S:5109 E:5115 ||| NNS
)  ||| S:5115 E:5117 ||| -RRB-
and  ||| S:5117 E:5121 ||| CC
a  ||| S:5121 E:5133 ||| DT
single  ||| S:5133 E:5140 ||| JJ
protein  ||| S:5140 E:5148 ||| NN
band  ||| S:5148 E:5153 ||| NN
of  ||| S:5153 E:5156 ||| IN
120  ||| S:5156 E:5160 ||| CD
kD  ||| S:5160 E:5163 ||| NN
under  ||| S:5163 E:5169 ||| IN
non-reducing  ||| S:5169 E:5192 ||| JJ
conditions  ||| S:5192 E:5203 ||| NNS
( ||| S:5203 E:5204 ||| -LRB-
not  ||| S:5204 E:5208 ||| RB
shown ||| S:5208 E:5213 ||| VBN
)  ||| S:5213 E:5215 ||| -RRB-
but  ||| S:5215 E:5219 ||| CC
no  ||| S:5219 E:5222 ||| DT
other  ||| S:5222 E:5228 ||| JJ
protein  ||| S:5228 E:5236 ||| NN
bands  ||| S:5236 E:5242 ||| NNS
when  ||| S:5242 E:5257 ||| WRB
lysates  ||| S:5257 E:5265 ||| NNS
were  ||| S:5265 E:5270 ||| VBD
prepared  ||| S:5270 E:5279 ||| VBN
in  ||| S:5279 E:5282 ||| IN
1 ||| S:5282 E:5283 ||| CD
%  ||| S:5283 E:5285 ||| NN
Triton  ||| S:5285 E:5292 ||| NNP
XI  ||| S:5292 E:5295 ||| NNP
00  ||| S:5295 E:5298 ||| CD
detergent ||| S:5298 E:5307 ||| NN
.  ||| S:5307 E:5319 ||| .
However ||| S:5319 E:5326 ||| RB
,  ||| S:5326 E:5328 ||| ,
in  ||| S:5328 E:5331 ||| IN
the  ||| S:5331 E:5335 ||| DT
less  ||| S:5335 E:5340 ||| RBR
stringent  ||| S:5340 E:5350 ||| JJ
Brij  ||| S:5350 E:5355 ||| NNP
58  ||| S:5355 E:5358 ||| CD
detergent ||| S:5358 E:5367 ||| NN
,  ||| S:5367 E:5369 ||| ,
mAb  ||| S:5369 E:5383 ||| NNP
6B12  ||| S:5383 E:5388 ||| NNP
co-immunoprecipitated  ||| S:5388 E:5410 ||| NNP
an  ||| S:5410 E:5413 ||| DT
integrin-like  ||| S:5413 E:5427 ||| JJ
protein  ||| S:5427 E:5435 ||| NN
band  ||| S:5435 E:5450 ||| NN
of  ||| S:5450 E:5453 ||| IN
130  ||| S:5453 E:5457 ||| CD
kD  ||| S:5457 E:5460 ||| NNS
( ||| S:5460 E:5461 ||| -LRB-
Fig.  ||| S:5461 E:5466 ||| CD
1 ||| S:5466 E:5467 ||| CD
,  ||| S:5467 E:5469 ||| ,
lane  ||| S:5469 E:5474 ||| JJ
b ||| S:5474 E:5475 ||| NN
,  ||| S:5475 E:5477 ||| ,
dotted  ||| S:5477 E:5484 ||| JJ
arrow ||| S:5484 E:5489 ||| NN
) ||| S:5489 E:5490 ||| -RRB-
.  ||| S:5490 E:5492 ||| .
Similar  ||| S:5492 E:5500 ||| JJ
results  ||| S:5500 E:5518 ||| NNS
were  ||| S:5518 E:5523 ||| VBD
noted  ||| S:5523 E:5529 ||| VBN
when  ||| S:5529 E:5534 ||| WRB
CHAPS  ||| S:5534 E:5540 ||| NNP
or  ||| S:5540 E:5543 ||| CC
Brij  ||| S:5543 E:5548 ||| NNP
99  ||| S:5548 E:5551 ||| CD
detergents  ||| S:5551 E:5562 ||| NNS
were  ||| S:5562 E:5567 ||| VBD
used  ||| S:5567 E:5582 ||| VBN
( ||| S:5582 E:5583 ||| -LRB-
not  ||| S:5583 E:5587 ||| RB
shown ||| S:5587 E:5592 ||| VBN
) ||| S:5592 E:5593 ||| -RRB-
.  ||| S:5593 E:5605 ||| .
Because  ||| S:5605 E:5613 ||| IN
the  ||| S:5613 E:5617 ||| DT
proteins  ||| S:5617 E:5626 ||| NNS
recognized  ||| S:5626 E:5637 ||| VBN
by  ||| S:5637 E:5640 ||| IN
6B12  ||| S:5640 E:5645 ||| NNP
resembled  ||| S:5645 E:5655 ||| VBD
the  ||| S:5655 E:5669 ||| DT
disulfide-linked  ||| S:5669 E:5686 ||| JJ
85  ||| S:5686 E:5689 ||| CD
and  ||| S:5689 E:5693 ||| CC
35  ||| S:5693 E:5696 ||| CD
kD  ||| S:5696 E:5699 ||| JJ
subunits  ||| S:5699 E:5708 ||| NN
of  ||| S:5708 E:5711 ||| IN
CD98  ||| S:5711 E:5716 ||| NNP
[  ||| S:5716 E:5718 ||| -LRB-
38  ||| S:5718 E:5721 ||| CD
39  ||| S:5721 E:5724 ||| CD
]  ||| S:5724 E:5736 ||| -RRB-
,  ||| S:5736 E:5738 ||| ,
they  ||| S:5738 E:5743 ||| PRP
were  ||| S:5743 E:5748 ||| VBD
compared  ||| S:5748 E:5757 ||| VBN
to  ||| S:5757 E:5760 ||| TO
authentic  ||| S:5760 E:5770 ||| VB
CD98  ||| S:5770 E:5775 ||| RB
as  ||| S:5775 E:5778 ||| RB
precipitated  ||| S:5778 E:5801 ||| VBD
using  ||| S:5801 E:5807 ||| VBG
mAb  ||| S:5807 E:5811 ||| JJ
4F2 ||| S:5811 E:5814 ||| NN
.  ||| S:5814 E:5816 ||| .
Both  ||| S:5816 E:5821 ||| DT
mAb  ||| S:5821 E:5825 ||| JJ
4F2  ||| S:5825 E:5829 ||| NN
and  ||| S:5829 E:5833 ||| CC
mAb  ||| S:5833 E:5837 ||| NNP
6B12  ||| S:5837 E:5842 ||| NNP
precipitated  ||| S:5842 E:5865 ||| VBD
identical  ||| S:5865 E:5875 ||| JJ
patterns  ||| S:5875 E:5884 ||| NNS
of  ||| S:5884 E:5887 ||| IN
cell  ||| S:5887 E:5892 ||| NN
surface  ||| S:5892 E:5900 ||| NN
proteins ||| S:5900 E:5908 ||| NNS
,  ||| S:5908 E:5910 ||| ,
as  ||| S:5910 E:5913 ||| RB
seen  ||| S:5913 E:5918 ||| VBN
by  ||| S:5918 E:5931 ||| IN
reduced  ||| S:5931 E:5939 ||| JJ
SDS-PAGE  ||| S:5939 E:5948 ||| NN
( ||| S:5948 E:5949 ||| -LRB-
Fig.  ||| S:5949 E:5954 ||| NNP
1A ||| S:5954 E:5956 ||| NNP
,  ||| S:5956 E:5958 ||| ,
lanes  ||| S:5958 E:5964 ||| JJ
c ||| S:5964 E:5965 ||| NN
, ||| S:5965 E:5966 ||| ,
d ||| S:5966 E:5967 ||| LS
) ||| S:5967 E:5968 ||| -RRB-
.  ||| S:5968 E:5970 ||| .
Furthermore ||| S:5970 E:5981 ||| RB
,  ||| S:5981 E:5993 ||| ,
preincubation  ||| S:5993 E:6007 ||| VBG
of  ||| S:6007 E:6010 ||| IN
cell  ||| S:6010 E:6015 ||| NN
lysates  ||| S:6015 E:6023 ||| NN
with  ||| S:6023 E:6028 ||| IN
mAb  ||| S:6028 E:6032 ||| NNP
4F2  ||| S:6032 E:6036 ||| NNP
resulted  ||| S:6036 E:6045 ||| VBD
in  ||| S:6045 E:6058 ||| IN
loss  ||| S:6058 E:6063 ||| NN
of  ||| S:6063 E:6066 ||| IN
the  ||| S:6066 E:6070 ||| DT
antigen  ||| S:6070 E:6078 ||| NN
recognized  ||| S:6078 E:6089 ||| VBN
by  ||| S:6089 E:6092 ||| IN
mAb  ||| S:6092 E:6096 ||| NNP
6B12  ||| S:6096 E:6101 ||| NNP
( ||| S:6101 E:6102 ||| -LRB-
not  ||| S:6102 E:6106 ||| RB
shown ||| S:6106 E:6111 ||| VBN
) ||| S:6111 E:6112 ||| -RRB-
.  ||| S:6112 E:6124 ||| .
Upon  ||| S:6124 E:6129 ||| IN
addition  ||| S:6129 E:6138 ||| NN
of  ||| S:6138 E:6141 ||| IN
10  ||| S:6141 E:6144 ||| CD
mM  ||| S:6144 E:6147 ||| JJ
DTT  ||| S:6147 E:6151 ||| NN
to  ||| S:6151 E:6154 ||| TO
cell  ||| S:6154 E:6159 ||| NN
lysates ||| S:6159 E:6166 ||| NN
,  ||| S:6166 E:6168 ||| ,
mAb  ||| S:6168 E:6172 ||| NNP
6B12  ||| S:6172 E:6187 ||| NNP
immunoprecipitated  ||| S:6187 E:6206 ||| VBD
only  ||| S:6206 E:6211 ||| RB
a  ||| S:6211 E:6213 ||| DT
85  ||| S:6213 E:6216 ||| CD
kD  ||| S:6216 E:6219 ||| JJ
protein  ||| S:6219 E:6227 ||| NN
band ||| S:6227 E:6231 ||| NN
,  ||| S:6231 E:6233 ||| ,
consistent  ||| S:6233 E:6254 ||| JJ
with  ||| S:6254 E:6259 ||| IN
specific  ||| S:6259 E:6268 ||| JJ
recognition  ||| S:6268 E:6280 ||| NN
of  ||| S:6280 E:6283 ||| IN
the  ||| S:6283 E:6287 ||| DT
CD98  ||| S:6287 E:6292 ||| JJ
heavy  ||| S:6292 E:6298 ||| JJ
chain ||| S:6298 E:6303 ||| NN
.  ||| S:6303 E:6305 ||| .
Flow  ||| S:6305 E:6320 ||| NN
cytometry  ||| S:6320 E:6330 ||| NN
of  ||| S:6330 E:6333 ||| IN
CHO  ||| S:6333 E:6337 ||| NNP
cells  ||| S:6337 E:6343 ||| NNS
transfected  ||| S:6343 E:6355 ||| VBN
with  ||| S:6355 E:6360 ||| IN
CD98  ||| S:6360 E:6365 ||| CD
heavy  ||| S:6365 E:6371 ||| JJ
chain  ||| S:6371 E:6387 ||| NN
cDNA  ||| S:6387 E:6392 ||| NN
confirmed  ||| S:6392 E:6402 ||| VBD
that  ||| S:6402 E:6407 ||| IN
the  ||| S:6407 E:6411 ||| DT
CD98  ||| S:6411 E:6416 ||| JJ
heavy  ||| S:6416 E:6422 ||| JJ
chain  ||| S:6422 E:6428 ||| NN
is  ||| S:6428 E:6431 ||| VBZ
the  ||| S:6431 E:6435 ||| DT
6B12  ||| S:6435 E:6450 ||| JJ
antigen  ||| S:6450 E:6458 ||| NN
( ||| S:6458 E:6459 ||| -LRB-
Fig.  ||| S:6459 E:6464 ||| NNP
1B ||| S:6464 E:6466 ||| NNP
) ||| S:6466 E:6467 ||| -RRB-
.  ||| S:6467 E:6469 ||| .
Also ||| S:6469 E:6473 ||| RB
,  ||| S:6473 E:6475 ||| ,
by  ||| S:6475 E:6478 ||| IN
flow  ||| S:6478 E:6483 ||| NN
cytometry  ||| S:6483 E:6493 ||| VBD
the  ||| S:6493 E:6497 ||| DT
6B12  ||| S:6497 E:6512 ||| JJ
antigen  ||| S:6512 E:6520 ||| NN
was  ||| S:6520 E:6524 ||| VBD
present  ||| S:6524 E:6532 ||| JJ
at  ||| S:6532 E:6535 ||| IN
high  ||| S:6535 E:6540 ||| JJ
levels  ||| S:6540 E:6547 ||| NNS
on  ||| S:6547 E:6550 ||| IN
all  ||| S:6550 E:6554 ||| DT
human  ||| S:6554 E:6560 ||| JJ
cell  ||| S:6560 E:6575 ||| NN
lines  ||| S:6575 E:6581 ||| NNS
tested  ||| S:6581 E:6588 ||| VBD
( ||| S:6588 E:6589 ||| -LRB-
more  ||| S:6589 E:6594 ||| JJR
than  ||| S:6594 E:6599 ||| IN
20 ||| S:6599 E:6601 ||| CD
)  ||| S:6601 E:6603 ||| -RRB-
as  ||| S:6603 E:6606 ||| RB
expected  ||| S:6606 E:6615 ||| VBN
for  ||| S:6615 E:6619 ||| IN
CD98 ||| S:6619 E:6623 ||| CD
.  ||| S:6623 E:6653 ||| .
Specificity  ||| S:6653 E:6665 ||| NNP
of  ||| S:6665 E:6668 ||| IN
CD98-integrin  ||| S:6668 E:6682 ||| CD
association  ||| S:6682 E:6704 ||| NN
To  ||| S:6704 E:6707 ||| TO
identify  ||| S:6707 E:6716 ||| VB
the  ||| S:6716 E:6720 ||| DT
integrin-like  ||| S:6720 E:6734 ||| JJ
130  ||| S:6734 E:6738 ||| CD
kD  ||| S:6738 E:6741 ||| JJ
protein ||| S:6741 E:6748 ||| NN
( ||| S:6748 E:6749 ||| -LRB-
s ||| S:6749 E:6750 ||| LS
)  ||| S:6750 E:6762 ||| -RRB-
co-precipitating  ||| S:6762 E:6779 ||| JJ
with  ||| S:6779 E:6784 ||| IN
CD98 ||| S:6784 E:6788 ||| NNP
,  ||| S:6788 E:6790 ||| ,
immune  ||| S:6790 E:6797 ||| JJ
complexes  ||| S:6797 E:6807 ||| NNS
prepared  ||| S:6807 E:6826 ||| VBN
from  ||| S:6826 E:6831 ||| IN
HT1080  ||| S:6831 E:6838 ||| CD
cells  ||| S:6838 E:6844 ||| NNS
were  ||| S:6844 E:6849 ||| VBD
dissociated  ||| S:6849 E:6861 ||| JJ
and  ||| S:6861 E:6865 ||| CC
reprecipitated  ||| S:6865 E:6890 ||| NN
with  ||| S:6890 E:6895 ||| IN
mAb  ||| S:6895 E:6899 ||| JJ
against  ||| S:6899 E:6907 ||| IN
various  ||| S:6907 E:6915 ||| JJ
cell  ||| S:6915 E:6920 ||| NN
surface  ||| S:6920 E:6928 ||| NN
molecules ||| S:6928 E:6937 ||| NNS
.  ||| S:6937 E:6939 ||| .
From  ||| S:6939 E:6954 ||| IN
CD98  ||| S:6954 E:6959 ||| NNP
immunoprecipitates  ||| S:6959 E:6978 ||| VBD
we  ||| S:6978 E:6981 ||| PRP
recovered  ||| S:6981 E:6991 ||| VBD
α3β1  ||| S:6991 E:6996 ||| CD
integrin ||| S:6996 E:7004 ||| NN
,  ||| S:7004 E:7006 ||| ,
but  ||| S:7006 E:7020 ||| CC
not  ||| S:7020 E:7024 ||| RB
other  ||| S:7024 E:7030 ||| JJ
cell  ||| S:7030 E:7035 ||| NN
surface  ||| S:7035 E:7043 ||| NN
molecules ||| S:7043 E:7052 ||| NNS
,  ||| S:7052 E:7054 ||| ,
including  ||| S:7054 E:7064 ||| VBG
the  ||| S:7064 E:7068 ||| DT
LDL  ||| S:7068 E:7082 ||| NNP
receptor ||| S:7082 E:7090 ||| NN
,  ||| S:7090 E:7092 ||| ,
HLA  ||| S:7092 E:7096 ||| NNP
class  ||| S:7096 E:7102 ||| NN
I ||| S:7102 E:7103 ||| PRP
,  ||| S:7103 E:7105 ||| ,
the  ||| S:7105 E:7109 ||| DT
metalloprotease  ||| S:7109 E:7125 ||| JJ
regulator  ||| S:7125 E:7145 ||| NN
EMMPRIN  ||| S:7145 E:7153 ||| NNP
( ||| S:7153 E:7154 ||| -LRB-
CD  ||| S:7154 E:7157 ||| NNP
147 ||| S:7157 E:7160 ||| CD
) ||| S:7160 E:7161 ||| -RRB-
,  ||| S:7161 E:7163 ||| ,
CD71 ||| S:7163 E:7167 ||| NNP
,  ||| S:7167 E:7169 ||| ,
or  ||| S:7169 E:7172 ||| CC
CD  ||| S:7172 E:7175 ||| NNP
109  ||| S:7175 E:7179 ||| CD
( ||| S:7179 E:7180 ||| -LRB-
Fig.  ||| S:7180 E:7185 ||| NNP
2A ||| S:7185 E:7187 ||| NNP
) ||| S:7187 E:7188 ||| -RRB-
.  ||| S:7188 E:7190 ||| .
Several  ||| S:7190 E:7208 ||| JJ
other  ||| S:7208 E:7214 ||| JJ
β1  ||| S:7214 E:7217 ||| CD
integrins  ||| S:7217 E:7227 ||| NNS
that  ||| S:7227 E:7232 ||| WDT
are  ||| S:7232 E:7236 ||| VBP
abundant  ||| S:7236 E:7245 ||| VBN
on  ||| S:7245 E:7248 ||| IN
HT1080  ||| S:7248 E:7255 ||| CD
cells  ||| S:7255 E:7271 ||| NNS
( ||| S:7271 E:7272 ||| -LRB-
α3β1 ||| S:7272 E:7276 ||| NNP
,  ||| S:7276 E:7278 ||| ,
α2β1 ||| S:7278 E:7282 ||| NNP
,  ||| S:7282 E:7284 ||| ,
α5β1 ||| S:7284 E:7288 ||| NNP
,  ||| S:7288 E:7290 ||| ,
and  ||| S:7290 E:7294 ||| CC
α6β1 ||| S:7294 E:7298 ||| CD
)  ||| S:7298 E:7300 ||| -RRB-
also  ||| S:7300 E:7305 ||| RB
could  ||| S:7305 E:7311 ||| MD
be  ||| S:7311 E:7324 ||| VB
re-precipitated  ||| S:7324 E:7340 ||| JJ
from  ||| S:7340 E:7345 ||| IN
CD98  ||| S:7345 E:7350 ||| CD
immunoprecipitates  ||| S:7350 E:7369 ||| NNS
( ||| S:7369 E:7370 ||| -LRB-
Fig.  ||| S:7370 E:7375 ||| NNP
2C ||| S:7375 E:7377 ||| NNP
) ||| S:7377 E:7378 ||| -RRB-
.  ||| S:7378 E:7390 ||| .
Using  ||| S:7390 E:7396 ||| VBG
the  ||| S:7396 E:7400 ||| DT
same  ||| S:7400 E:7405 ||| JJ
experimental  ||| S:7405 E:7418 ||| JJ
conditions ||| S:7418 E:7428 ||| NNS
,  ||| S:7428 E:7430 ||| ,
we  ||| S:7430 E:7433 ||| PRP
were  ||| S:7433 E:7438 ||| VBD
unable  ||| S:7438 E:7445 ||| JJ
to  ||| S:7445 E:7458 ||| TO
detect  ||| S:7458 E:7465 ||| VB
α4β1  ||| S:7465 E:7470 ||| CD
in  ||| S:7470 E:7473 ||| IN
CD98  ||| S:7473 E:7478 ||| NNP
immunoprecitates  ||| S:7478 E:7495 ||| VBD
prepared  ||| S:7495 E:7504 ||| VBN
from  ||| S:7504 E:7509 ||| IN
the  ||| S:7509 E:7523 ||| DT
rhabdomyosarcoma  ||| S:7523 E:7540 ||| JJ
cell  ||| S:7540 E:7545 ||| NN
line  ||| S:7545 E:7550 ||| NN
RD ||| S:7550 E:7552 ||| NNP
,  ||| S:7552 E:7554 ||| ,
the  ||| S:7554 E:7558 ||| DT
lymphoblastoid  ||| S:7558 E:7573 ||| JJ
cell  ||| S:7573 E:7588 ||| NN
line  ||| S:7588 E:7593 ||| NN
Molt4 ||| S:7593 E:7598 ||| NN
,  ||| S:7598 E:7600 ||| ,
or  ||| S:7600 E:7603 ||| CC
K562  ||| S:7603 E:7608 ||| CD
cells  ||| S:7608 E:7614 ||| NNS
transfected  ||| S:7614 E:7626 ||| VBN
with  ||| S:7626 E:7631 ||| IN
α4  ||| S:7631 E:7634 ||| CD
integrin  ||| S:7634 E:7653 ||| NNS
( ||| S:7653 E:7654 ||| -LRB-
not  ||| S:7654 E:7658 ||| RB
shown ||| S:7658 E:7663 ||| VBN
) ||| S:7663 E:7664 ||| -RRB-
.  ||| S:7664 E:7666 ||| .
However ||| S:7666 E:7673 ||| RB
,  ||| S:7673 E:7675 ||| ,
we  ||| S:7675 E:7678 ||| PRP
did  ||| S:7678 E:7682 ||| VBD
observe  ||| S:7682 E:7700 ||| JJ
co-immunoprecipitation  ||| S:7700 E:7723 ||| NN
of  ||| S:7723 E:7726 ||| IN
CD98  ||| S:7726 E:7731 ||| CD
with  ||| S:7731 E:7736 ||| IN
α4β1  ||| S:7736 E:7741 ||| CD
integrin  ||| S:7741 E:7750 ||| NN
in  ||| S:7750 E:7753 ||| IN
the  ||| S:7753 E:7767 ||| DT
presence  ||| S:7767 E:7776 ||| NN
of  ||| S:7776 E:7779 ||| IN
2  ||| S:7779 E:7781 ||| CD
mM  ||| S:7781 E:7784 ||| JJ
manganese  ||| S:7784 E:7794 ||| NNS
( ||| S:7794 E:7795 ||| -LRB-
not  ||| S:7795 E:7799 ||| RB
shown ||| S:7799 E:7804 ||| VBN
) ||| S:7804 E:7805 ||| -RRB-
.  ||| S:7805 E:7807 ||| .
The  ||| S:7807 E:7811 ||| DT
precise  ||| S:7811 E:7819 ||| JJ
role  ||| S:7819 E:7834 ||| NN
of  ||| S:7834 E:7837 ||| IN
manganese  ||| S:7837 E:7847 ||| NN
is  ||| S:7847 E:7850 ||| VBZ
unclear ||| S:7850 E:7857 ||| JJ
.  ||| S:7857 E:7859 ||| .
Incubation  ||| S:7859 E:7870 ||| NNP
with  ||| S:7870 E:7875 ||| IN
anti-β1  ||| S:7875 E:7893 ||| NNP
' ||| S:7893 E:7894 ||| POS
activating  ||| S:7894 E:7905 ||| JJ
antibody ||| S:7905 E:7913 ||| NN
'  ||| S:7913 E:7915 ||| POS
TS2 ||| S:7915 E:7918 ||| CD
/ ||| S:7918 E:7919 ||| CD
16  ||| S:7919 E:7922 ||| CD
( ||| S:7922 E:7923 ||| -LRB-
not  ||| S:7923 E:7927 ||| RB
shown ||| S:7927 E:7932 ||| VBN
)  ||| S:7932 E:7934 ||| -RRB-
did  ||| S:7934 E:7938 ||| VBD
not  ||| S:7938 E:7942 ||| RB
mimic  ||| S:7942 E:7958 ||| VB
the  ||| S:7958 E:7962 ||| DT
effects  ||| S:7962 E:7970 ||| NNS
of  ||| S:7970 E:7973 ||| IN
manganese  ||| S:7973 E:7983 ||| NN
on  ||| S:7983 E:7986 ||| IN
α4β1-CD98  ||| S:7986 E:7996 ||| CD
association ||| S:7996 E:8007 ||| NN
.  ||| S:8007 E:8009 ||| .
Thus ||| S:8009 E:8013 ||| RB
,  ||| S:8013 E:8025 ||| ,
although  ||| S:8025 E:8034 ||| IN
manganese  ||| S:8034 E:8044 ||| NN
is  ||| S:8044 E:8047 ||| VBZ
well  ||| S:8047 E:8052 ||| RB
known  ||| S:8052 E:8058 ||| VBN
to  ||| S:8058 E:8061 ||| TO
"activate ||| S:8061 E:8070 ||| CD
"  ||| S:8070 E:8072 ||| ``
β1  ||| S:8072 E:8085 ||| FW
integrins  ||| S:8085 E:8095 ||| FW
[  ||| S:8095 E:8097 ||| -LRB-
60  ||| S:8097 E:8100 ||| CD
]  ||| S:8100 E:8102 ||| -RRB-
,  ||| S:8102 E:8104 ||| ,
this  ||| S:8104 E:8109 ||| DT
activation  ||| S:8109 E:8120 ||| NN
may  ||| S:8120 E:8124 ||| MD
not  ||| S:8124 E:8128 ||| RB
be  ||| S:8128 E:8131 ||| VB
relevant  ||| S:8131 E:8140 ||| JJ
to  ||| S:8140 E:8153 ||| TO
α4β1-CD98  ||| S:8153 E:8163 ||| CD
association ||| S:8163 E:8174 ||| NN
.  ||| S:8174 E:8176 ||| .
Comparison  ||| S:8176 E:8187 ||| NN
of  ||| S:8187 E:8190 ||| IN
material  ||| S:8190 E:8199 ||| NN
isolated  ||| S:8199 E:8218 ||| VBN
from  ||| S:8218 E:8223 ||| IN
CD98  ||| S:8223 E:8228 ||| CD
immunoprecipitates  ||| S:8228 E:8247 ||| NN
with  ||| S:8247 E:8252 ||| IN
total  ||| S:8252 E:8258 ||| JJ
amounts  ||| S:8258 E:8266 ||| NNS
of  ||| S:8266 E:8269 ||| IN
each  ||| S:8269 E:8284 ||| DT
integrin  ||| S:8284 E:8293 ||| NN
on  ||| S:8293 E:8296 ||| IN
the  ||| S:8296 E:8300 ||| DT
cell  ||| S:8300 E:8305 ||| NN
surface  ||| S:8305 E:8313 ||| NN
indicates  ||| S:8313 E:8323 ||| VBZ
that  ||| S:8323 E:8328 ||| IN
approximately  ||| S:8328 E:8352 ||| RB
5-10 ||| S:8352 E:8356 ||| JJ
%  ||| S:8356 E:8358 ||| NN
of  ||| S:8358 E:8361 ||| IN
each  ||| S:8361 E:8366 ||| DT
integrin  ||| S:8366 E:8375 ||| NN
is  ||| S:8375 E:8378 ||| VBZ
associated  ||| S:8378 E:8389 ||| VBN
with  ||| S:8389 E:8394 ||| IN
CD98  ||| S:8394 E:8399 ||| NNP
( ||| S:8399 E:8400 ||| -LRB-
Fig.  ||| S:8400 E:8405 ||| NNP
2C ||| S:8405 E:8407 ||| NNP
,  ||| S:8407 E:8419 ||| ,
compare  ||| S:8419 E:8427 ||| VBP
lanes  ||| S:8427 E:8433 ||| JJ
a-d  ||| S:8433 E:8437 ||| NN
with  ||| S:8437 E:8442 ||| IN
e-h ||| S:8442 E:8445 ||| NNP
) ||| S:8445 E:8446 ||| -RRB-
.  ||| S:8446 E:8448 ||| .
In  ||| S:8448 E:8451 ||| IN
a  ||| S:8451 E:8453 ||| DT
reciprocal  ||| S:8453 E:8464 ||| JJ
experiment ||| S:8464 E:8474 ||| NN
,  ||| S:8474 E:8486 ||| ,
CD98  ||| S:8486 E:8491 ||| CD
heavy  ||| S:8491 E:8497 ||| JJ
chain  ||| S:8497 E:8503 ||| NN
was  ||| S:8503 E:8507 ||| VBD
re-precipitated  ||| S:8507 E:8523 ||| JJ
from  ||| S:8523 E:8528 ||| IN
an  ||| S:8528 E:8531 ||| DT
α3β1  ||| S:8531 E:8546 ||| FW
integrin  ||| S:8546 E:8555 ||| FW
immunoprecipitate  ||| S:8555 E:8573 ||| FW
( ||| S:8573 E:8574 ||| -LRB-
Fig.  ||| S:8574 E:8579 ||| NNP
2B ||| S:8579 E:8581 ||| NNP
,  ||| S:8581 E:8583 ||| ,
lane  ||| S:8583 E:8588 ||| FW
a ||| S:8588 E:8589 ||| FW
)  ||| S:8589 E:8591 ||| -RRB-
at  ||| S:8591 E:8594 ||| IN
a  ||| S:8594 E:8596 ||| DT
level  ||| S:8596 E:8612 ||| NN
comparable  ||| S:8612 E:8623 ||| JJ
to  ||| S:8623 E:8626 ||| TO
re-precipitated  ||| S:8626 E:8642 ||| NNP
CD81  ||| S:8642 E:8647 ||| NNP
( ||| S:8647 E:8648 ||| -LRB-
lane  ||| S:8648 E:8653 ||| UH
b ||| S:8653 E:8654 ||| LS
) ||| S:8654 E:8655 ||| -RRB-
,  ||| S:8655 E:8657 ||| ,
a  ||| S:8657 E:8659 ||| DT
molecule  ||| S:8659 E:8678 ||| NN
shown  ||| S:8678 E:8684 ||| VBN
previously  ||| S:8684 E:8695 ||| RB
to  ||| S:8695 E:8698 ||| TO
associate  ||| S:8698 E:8708 ||| NN
with  ||| S:8708 E:8713 ||| IN
α3β1  ||| S:8713 E:8718 ||| CD
integrins  ||| S:8718 E:8728 ||| NNS
[  ||| S:8728 E:8730 ||| -LRB-
32  ||| S:8730 E:8733 ||| CD
]  ||| S:8733 E:8745 ||| -RRB-
.  ||| S:8745 E:8747 ||| .
Results  ||| S:8747 E:8755 ||| NNS
in  ||| S:8755 E:8758 ||| IN
Fig.  ||| S:8758 E:8763 ||| CD
2Aand  ||| S:8763 E:8769 ||| CD
2Bindicate  ||| S:8769 E:8780 ||| CD
that  ||| S:8780 E:8785 ||| IN
CD98-integrin  ||| S:8785 E:8809 ||| CD
complexes  ||| S:8809 E:8819 ||| NNS
are  ||| S:8819 E:8823 ||| VBP
distinct  ||| S:8823 E:8832 ||| JJ
from  ||| S:8832 E:8837 ||| IN
previously  ||| S:8837 E:8848 ||| RB
described  ||| S:8848 E:8868 ||| VBD
integrin-CD81  ||| S:8868 E:8882 ||| CD
[  ||| S:8882 E:8884 ||| -LRB-
32  ||| S:8884 E:8887 ||| CD
40  ||| S:8887 E:8890 ||| CD
]  ||| S:8890 E:8892 ||| -RRB-
and  ||| S:8892 E:8896 ||| CC
integrin-CD147 ||| S:8896 E:8910 ||| NNP
/ ||| S:8910 E:8911 ||| NNP
EMMPRIN  ||| S:8911 E:8919 ||| NNP
[  ||| S:8919 E:8921 ||| -LRB-
31  ||| S:8921 E:8924 ||| CD
]  ||| S:8924 E:8936 ||| -RRB-
complexes ||| S:8936 E:8945 ||| NNS
.  ||| S:8945 E:8957 ||| .
Because  ||| S:8957 E:8965 ||| IN
not  ||| S:8965 E:8969 ||| RB
all  ||| S:8969 E:8973 ||| DT
β1  ||| S:8973 E:8976 ||| NNP
integrins  ||| S:8976 E:8986 ||| VBD
associated  ||| S:8986 E:8997 ||| VBN
constitutively  ||| S:8997 E:9022 ||| VBN
with  ||| S:9022 E:9027 ||| IN
CD98  ||| S:9027 E:9032 ||| NNP
( ||| S:9032 E:9033 ||| -LRB-
in  ||| S:9033 E:9036 ||| IN
the  ||| S:9036 E:9040 ||| DT
absence  ||| S:9040 E:9048 ||| NN
of  ||| S:9048 E:9051 ||| IN
manganese ||| S:9051 E:9060 ||| CD
) ||| S:9060 E:9061 ||| -RRB-
,  ||| S:9061 E:9063 ||| ,
the  ||| S:9063 E:9067 ||| DT
α  ||| S:9067 E:9069 ||| JJ
chain  ||| S:9069 E:9075 ||| NN
must  ||| S:9075 E:9090 ||| MD
help  ||| S:9090 E:9095 ||| VB
regulate  ||| S:9095 E:9104 ||| JJ
specificity  ||| S:9104 E:9116 ||| NN
of  ||| S:9116 E:9119 ||| IN
CD98  ||| S:9119 E:9124 ||| CD
association ||| S:9124 E:9135 ||| NN
.  ||| S:9135 E:9137 ||| .
Notably ||| S:9137 E:9144 ||| RB
,  ||| S:9144 E:9156 ||| ,
α3  ||| S:9156 E:9159 ||| NNP
with  ||| S:9159 E:9164 ||| IN
a  ||| S:9164 E:9166 ||| DT
truncated  ||| S:9166 E:9176 ||| JJ
cytoplasmic  ||| S:9176 E:9188 ||| JJ
tail ||| S:9188 E:9192 ||| NN
,  ||| S:9192 E:9194 ||| ,
and  ||| S:9194 E:9198 ||| CC
wild-type  ||| S:9198 E:9208 ||| JJ
α3  ||| S:9208 E:9221 ||| NN
associated  ||| S:9221 E:9232 ||| VBN
equally  ||| S:9232 E:9240 ||| RB
well  ||| S:9240 E:9245 ||| RB
with  ||| S:9245 E:9250 ||| IN
CD98  ||| S:9250 E:9255 ||| NNP
( ||| S:9255 E:9256 ||| -LRB-
Fig.  ||| S:9256 E:9261 ||| NNP
2D ||| S:9261 E:9263 ||| NNP
,  ||| S:9263 E:9265 ||| ,
lanes  ||| S:9265 E:9271 ||| JJ
c ||| S:9271 E:9272 ||| NN
, ||| S:9272 E:9273 ||| ,
d ||| S:9273 E:9274 ||| LS
) ||| S:9274 E:9275 ||| -RRB-
.  ||| S:9275 E:9287 ||| .
Thus ||| S:9287 E:9291 ||| RB
,  ||| S:9291 E:9293 ||| ,
specificity  ||| S:9293 E:9305 ||| NN
for  ||| S:9305 E:9309 ||| IN
constitutive  ||| S:9309 E:9322 ||| JJ
association  ||| S:9322 E:9334 ||| NN
with  ||| S:9334 E:9339 ||| IN
CD98  ||| S:9339 E:9354 ||| NNP
may  ||| S:9354 E:9358 ||| MD
reside  ||| S:9358 E:9365 ||| VB
in  ||| S:9365 E:9368 ||| IN
integrin  ||| S:9368 E:9377 ||| JJ
α  ||| S:9377 E:9379 ||| JJ
chain  ||| S:9379 E:9385 ||| NN
extracellular  ||| S:9385 E:9399 ||| NNS
or  ||| S:9399 E:9412 ||| CC
transmembrane  ||| S:9412 E:9426 ||| JJ
domains ||| S:9426 E:9433 ||| NN
.  ||| S:9433 E:9435 ||| .
To  ||| S:9435 E:9438 ||| TO
check  ||| S:9438 E:9444 ||| VB
whether  ||| S:9444 E:9452 ||| IN
CD98  ||| S:9452 E:9457 ||| NNP
is  ||| S:9457 E:9460 ||| VBZ
a  ||| S:9460 E:9462 ||| DT
ligand  ||| S:9462 E:9479 ||| NN
for  ||| S:9479 E:9483 ||| IN
α3β1  ||| S:9483 E:9488 ||| CD
integrin ||| S:9488 E:9496 ||| NN
,  ||| S:9496 E:9498 ||| ,
we  ||| S:9498 E:9501 ||| PRP
used  ||| S:9501 E:9506 ||| VBD
K562  ||| S:9506 E:9511 ||| CD
cells  ||| S:9511 E:9517 ||| NNS
transfected  ||| S:9517 E:9529 ||| VBN
with  ||| S:9529 E:9544 ||| IN
wild  ||| S:9544 E:9549 ||| JJ
type  ||| S:9549 E:9554 ||| NN
α3 ||| S:9554 E:9556 ||| NN
,  ||| S:9556 E:9558 ||| ,
or  ||| S:9558 E:9561 ||| CC
α3  ||| S:9561 E:9564 ||| CD
mutants  ||| S:9564 E:9572 ||| JJ
deficient  ||| S:9572 E:9582 ||| NN
in  ||| S:9582 E:9585 ||| IN
adhesion  ||| S:9585 E:9594 ||| VBG
to  ||| S:9594 E:9597 ||| TO
α3  ||| S:9597 E:9610 ||| CD
ligands  ||| S:9610 E:9618 ||| CD
laminin  ||| S:9618 E:9626 ||| CD
5  ||| S:9626 E:9628 ||| CD
( ||| S:9628 E:9629 ||| -LRB-
W220A ||| S:9629 E:9634 ||| NNP
)  ||| S:9634 E:9636 ||| -RRB-
and  ||| S:9636 E:9640 ||| CC
invasin  ||| S:9640 E:9648 ||| NNS
( ||| S:9648 E:9649 ||| -LRB-
Y218A ||| S:9649 E:9654 ||| NNP
)  ||| S:9654 E:9656 ||| -RRB-
[  ||| S:9656 E:9658 ||| -LRB-
41  ||| S:9658 E:9661 ||| CD
]  ||| S:9661 E:9663 ||| -RRB-
.  ||| S:9663 E:9675 ||| .
All  ||| S:9675 E:9679 ||| DT
of  ||| S:9679 E:9682 ||| IN
these  ||| S:9682 E:9688 ||| DT
α3  ||| S:9688 E:9691 ||| CD
proteins  ||| S:9691 E:9700 ||| NNS
constructs  ||| S:9700 E:9711 ||| VBP
associated  ||| S:9711 E:9722 ||| VBN
with  ||| S:9722 E:9727 ||| IN
CD98  ||| S:9727 E:9742 ||| NNP
( ||| S:9742 E:9743 ||| -LRB-
Fig.  ||| S:9743 E:9748 ||| NNP
2E ||| S:9748 E:9750 ||| NNP
) ||| S:9750 E:9751 ||| -RRB-
.  ||| S:9751 E:9753 ||| .
Notably ||| S:9753 E:9760 ||| RB
,  ||| S:9760 E:9762 ||| ,
2  ||| S:9762 E:9764 ||| CD
mM  ||| S:9764 E:9767 ||| JJ
EDTA  ||| S:9767 E:9772 ||| NNP
had  ||| S:9772 E:9776 ||| VBD
no  ||| S:9776 E:9779 ||| DT
inhibitory  ||| S:9779 E:9790 ||| JJ
effect  ||| S:9790 E:9797 ||| NN
on  ||| S:9797 E:9810 ||| IN
constitutive  ||| S:9810 E:9823 ||| CD
integrin-CD98  ||| S:9823 E:9837 ||| CD
associations  ||| S:9837 E:9850 ||| NNS
( ||| S:9850 E:9851 ||| -LRB-
not  ||| S:9851 E:9855 ||| RB
shown ||| S:9855 E:9860 ||| VBN
) ||| S:9860 E:9861 ||| -RRB-
.  ||| S:9861 E:9873 ||| .
Thus ||| S:9873 E:9877 ||| RB
,  ||| S:9877 E:9879 ||| ,
CD98  ||| S:9879 E:9884 ||| VBZ
itself  ||| S:9884 E:9891 ||| PRP
does  ||| S:9891 E:9896 ||| VBZ
not  ||| S:9896 E:9900 ||| RB
appear  ||| S:9900 E:9907 ||| VB
to  ||| S:9907 E:9910 ||| TO
be  ||| S:9910 E:9913 ||| VB
acting  ||| S:9913 E:9920 ||| VBG
as  ||| S:9920 E:9923 ||| IN
an  ||| S:9923 E:9936 ||| DT
integrin  ||| S:9936 E:9945 ||| JJ
ligand ||| S:9945 E:9951 ||| NN
.  ||| S:9951 E:9953 ||| .
We  ||| S:9953 E:9956 ||| PRP
were  ||| S:9956 E:9961 ||| VBD
unable  ||| S:9961 E:9968 ||| JJ
to  ||| S:9968 E:9971 ||| TO
demonstrate  ||| S:9971 E:9983 ||| VB
any  ||| S:9983 E:9997 ||| DT
changes  ||| S:9997 E:10005 ||| NNS
in  ||| S:10005 E:10008 ||| IN
the  ||| S:10008 E:10012 ||| DT
adhesive  ||| S:10012 E:10021 ||| NN
functions  ||| S:10021 E:10031 ||| NNS
of  ||| S:10031 E:10034 ||| IN
CHO  ||| S:10034 E:10038 ||| NNP
cells  ||| S:10038 E:10044 ||| NNS
upon  ||| S:10044 E:10059 ||| IN
CD98-transfection ||| S:10059 E:10076 ||| CD
.  ||| S:10076 E:10078 ||| .
However ||| S:10078 E:10085 ||| RB
,  ||| S:10085 E:10087 ||| ,
functional  ||| S:10087 E:10098 ||| JJ
effects  ||| S:10098 E:10106 ||| NNS
of  ||| S:10106 E:10119 ||| IN
transfected  ||| S:10119 E:10131 ||| JJ
human  ||| S:10131 E:10137 ||| JJ
CD98  ||| S:10137 E:10142 ||| NN
could  ||| S:10142 E:10148 ||| MD
be  ||| S:10148 E:10151 ||| VB
overshadowed  ||| S:10151 E:10164 ||| VBN
by  ||| S:10164 E:10167 ||| IN
an  ||| S:10167 E:10170 ||| DT
excess  ||| S:10170 E:10187 ||| NN
of  ||| S:10187 E:10190 ||| IN
endogenous  ||| S:10190 E:10201 ||| FW
hamster  ||| S:10201 E:10209 ||| FW
CD98 ||| S:10209 E:10213 ||| FW
.  ||| S:10213 E:10225 ||| .
Next  ||| S:10225 E:10230 ||| IN
we  ||| S:10230 E:10233 ||| PRP
asked  ||| S:10233 E:10239 ||| VBD
whether  ||| S:10239 E:10247 ||| IN
clustering  ||| S:10247 E:10258 ||| NN
of  ||| S:10258 E:10261 ||| IN
CD98  ||| S:10261 E:10266 ||| NNP
would  ||| S:10266 E:10272 ||| MD
induce  ||| S:10272 E:10289 ||| VB
selective  ||| S:10289 E:10299 ||| JJ
clustering  ||| S:10299 E:10310 ||| NN
of  ||| S:10310 E:10313 ||| IN
β1  ||| S:10313 E:10316 ||| CD
integrins ||| S:10316 E:10325 ||| NNS
.  ||| S:10325 E:10327 ||| .
On  ||| S:10327 E:10330 ||| IN
the  ||| S:10330 E:10334 ||| DT
surface  ||| S:10334 E:10342 ||| NN
of  ||| S:10342 E:10355 ||| IN
RD-A3  ||| S:10355 E:10361 ||| CD
cells ||| S:10361 E:10366 ||| NNS
,  ||| S:10366 E:10368 ||| ,
CD98  ||| S:10368 E:10373 ||| NNP
was  ||| S:10373 E:10377 ||| VBD
clustered  ||| S:10377 E:10387 ||| VBN
by  ||| S:10387 E:10390 ||| IN
incubation  ||| S:10390 E:10401 ||| NN
with  ||| S:10401 E:10416 ||| IN
anti-CD98  ||| S:10416 E:10426 ||| NNP
mAb  ||| S:10426 E:10430 ||| NNP
4F2 ||| S:10430 E:10433 ||| NNP
,  ||| S:10433 E:10435 ||| ,
followed  ||| S:10435 E:10444 ||| VBN
by  ||| S:10444 E:10447 ||| IN
incubation  ||| S:10447 E:10458 ||| NN
with  ||| S:10458 E:10463 ||| IN
rabbit  ||| S:10463 E:10480 ||| JJ
anti-mouse  ||| S:10480 E:10491 ||| JJ
antibody ||| S:10491 E:10499 ||| NN
.  ||| S:10499 E:10501 ||| .
Subsequent  ||| S:10501 E:10512 ||| JJ
incubation  ||| S:10512 E:10523 ||| NN
with  ||| S:10523 E:10528 ||| IN
anti-α3  ||| S:10528 E:10546 ||| NNP
mAb  ||| S:10546 E:10550 ||| NNP
directly  ||| S:10550 E:10559 ||| RB
conjugated  ||| S:10559 E:10570 ||| VBN
to  ||| S:10570 E:10573 ||| TO
Alexa-488  ||| S:10573 E:10583 ||| CD
revealed  ||| S:10583 E:10592 ||| NN
that  ||| S:10592 E:10597 ||| IN
α3β1  ||| S:10597 E:10612 ||| NNP
was  ||| S:10612 E:10616 ||| VBD
highly  ||| S:10616 E:10623 ||| RB
clustered  ||| S:10623 E:10633 ||| VBN
( ||| S:10633 E:10634 ||| -LRB-
Fig.  ||| S:10634 E:10639 ||| NNP
3C ||| S:10639 E:10641 ||| NNP
) ||| S:10641 E:10642 ||| -RRB-
,  ||| S:10642 E:10644 ||| ,
unless  ||| S:10644 E:10651 ||| IN
pre-clustering  ||| S:10651 E:10666 ||| JJ
of  ||| S:10666 E:10679 ||| IN
CD98  ||| S:10679 E:10684 ||| NNP
was  ||| S:10684 E:10688 ||| VBD
omitted  ||| S:10688 E:10696 ||| VBN
( ||| S:10696 E:10697 ||| -LRB-
Fig.  ||| S:10697 E:10702 ||| NNP
3A ||| S:10702 E:10704 ||| NNP
) ||| S:10704 E:10705 ||| -RRB-
.  ||| S:10705 E:10707 ||| .
In  ||| S:10707 E:10710 ||| IN
contrast ||| S:10710 E:10718 ||| NN
,  ||| S:10718 E:10720 ||| ,
staining  ||| S:10720 E:10729 ||| VBG
with  ||| S:10729 E:10744 ||| IN
anti-α4-Alexa-488  ||| S:10744 E:10762 ||| NNP
mAb  ||| S:10762 E:10766 ||| NNP
revealed  ||| S:10766 E:10775 ||| VBD
a  ||| S:10775 E:10777 ||| DT
diffuse  ||| S:10777 E:10785 ||| JJ
pattern  ||| S:10785 E:10793 ||| NN
of  ||| S:10793 E:10806 ||| IN
staining ||| S:10806 E:10814 ||| NN
,  ||| S:10814 E:10816 ||| ,
regardless  ||| S:10816 E:10827 ||| RB
of  ||| S:10827 E:10830 ||| IN
CD98  ||| S:10830 E:10835 ||| CD
clustering  ||| S:10835 E:10846 ||| NNS
( ||| S:10846 E:10847 ||| -LRB-
Fig.  ||| S:10847 E:10852 ||| NNP
3B ||| S:10852 E:10854 ||| NNP
,  ||| S:10854 E:10856 ||| ,
3D ||| S:10856 E:10858 ||| CD
) ||| S:10858 E:10859 ||| -RRB-
.  ||| S:10859 E:10861 ||| .
If  ||| S:10861 E:10874 ||| IN
no  ||| S:10874 E:10877 ||| DT
Alexa-488-conjugated  ||| S:10877 E:10898 ||| CD
antibodies  ||| S:10898 E:10909 ||| NNS
were  ||| S:10909 E:10914 ||| VBD
added ||| S:10914 E:10919 ||| VBN
,  ||| S:10919 E:10921 ||| ,
no  ||| S:10921 E:10934 ||| DT
staining  ||| S:10934 E:10943 ||| NN
was  ||| S:10943 E:10947 ||| VBD
observed  ||| S:10947 E:10956 ||| VBN
( ||| S:10956 E:10957 ||| -LRB-
not  ||| S:10957 E:10961 ||| RB
shown ||| S:10961 E:10966 ||| VBN
) ||| S:10966 E:10967 ||| -RRB-
.  ||| S:10967 E:10969 ||| .
Immunofluorescent  ||| S:10969 E:10997 ||| JJ
staining  ||| S:10997 E:11006 ||| NN
of  ||| S:11006 E:11009 ||| IN
both  ||| S:11009 E:11014 ||| DT
α3β1  ||| S:11014 E:11019 ||| NNP
and  ||| S:11019 E:11023 ||| CC
CD98  ||| S:11023 E:11028 ||| NNP
showed  ||| S:11028 E:11035 ||| VBD
that  ||| S:11035 E:11040 ||| IN
they  ||| S:11040 E:11045 ||| PRP
were  ||| S:11045 E:11060 ||| VBD
distributed  ||| S:11060 E:11072 ||| VBN
similarly  ||| S:11072 E:11082 ||| RB
on  ||| S:11082 E:11085 ||| IN
the  ||| S:11085 E:11089 ||| DT
cell  ||| S:11089 E:11094 ||| NN
surface  ||| S:11094 E:11102 ||| NN
of  ||| S:11102 E:11105 ||| IN
HT1080  ||| S:11105 E:11112 ||| NNP
and  ||| S:11112 E:11126 ||| CC
RD-A3  ||| S:11126 E:11132 ||| CD
cells  ||| S:11132 E:11138 ||| NNS
and  ||| S:11138 E:11142 ||| CC
partially  ||| S:11142 E:11152 ||| RB
co-localized  ||| S:11152 E:11165 ||| JJ
( ||| S:11165 E:11166 ||| -LRB-
not  ||| S:11166 E:11170 ||| RB
shown ||| S:11170 E:11175 ||| VBN
) ||| S:11175 E:11176 ||| -RRB-
.  ||| S:11176 E:11206 ||| .
CD98  ||| S:11206 E:11211 ||| NNP
mutation  ||| S:11211 E:11220 ||| NN
and  ||| S:11220 E:11224 ||| CC
sucrose  ||| S:11224 E:11232 ||| JJ
density  ||| S:11232 E:11240 ||| NNS
gradient  ||| S:11240 E:11259 ||| VBP
localization  ||| S:11259 E:11282 ||| VBG
The  ||| S:11282 E:11286 ||| DT
CD98  ||| S:11286 E:11291 ||| JJ
heavy  ||| S:11291 E:11297 ||| JJ
chain  ||| S:11297 E:11303 ||| NN
contains  ||| S:11303 E:11312 ||| VBZ
two  ||| S:11312 E:11316 ||| CD
extracellular  ||| S:11316 E:11340 ||| CD
cysteines ||| S:11340 E:11349 ||| NNS
.  ||| S:11349 E:11351 ||| .
Each  ||| S:11351 E:11356 ||| DT
of  ||| S:11356 E:11359 ||| IN
these  ||| S:11359 E:11365 ||| DT
cysteines  ||| S:11365 E:11375 ||| NN
was  ||| S:11375 E:11379 ||| VBD
mutated  ||| S:11379 E:11387 ||| VBN
to  ||| S:11387 E:11390 ||| TO
serine ||| S:11390 E:11396 ||| VB
,  ||| S:11396 E:11408 ||| ,
and  ||| S:11408 E:11412 ||| CC
the  ||| S:11412 E:11416 ||| DT
effects  ||| S:11416 E:11424 ||| NNS
on  ||| S:11424 E:11427 ||| IN
β1  ||| S:11427 E:11430 ||| CD
integrin  ||| S:11430 E:11439 ||| JJ
association  ||| S:11439 E:11451 ||| NN
were  ||| S:11451 E:11466 ||| VBD
evaluated ||| S:11466 E:11475 ||| VBN
.  ||| S:11475 E:11477 ||| .
Stably  ||| S:11477 E:11484 ||| NNP
expressed  ||| S:11484 E:11494 ||| VBD
human  ||| S:11494 E:11500 ||| JJ
CD98  ||| S:11500 E:11505 ||| CD
heavy  ||| S:11505 E:11511 ||| JJ
chain  ||| S:11511 E:11517 ||| NN
C330S  ||| S:11517 E:11533 ||| CD
mutant  ||| S:11533 E:11540 ||| NNS
retained  ||| S:11540 E:11549 ||| VBD
association  ||| S:11549 E:11561 ||| NN
with  ||| S:11561 E:11566 ||| IN
endogenous  ||| S:11566 E:11577 ||| JJ
murine  ||| S:11577 E:11584 ||| JJ
β1  ||| S:11584 E:11587 ||| NN
in  ||| S:11587 E:11600 ||| IN
NIH  ||| S:11600 E:11604 ||| NNP
3T3  ||| S:11604 E:11608 ||| NNP
cells ||| S:11608 E:11613 ||| NNS
,  ||| S:11613 E:11615 ||| ,
comparable  ||| S:11615 E:11626 ||| JJ
to  ||| S:11626 E:11629 ||| TO
that  ||| S:11629 E:11634 ||| DT
seen  ||| S:11634 E:11639 ||| VBN
for  ||| S:11639 E:11643 ||| IN
wild  ||| S:11643 E:11648 ||| JJ
type  ||| S:11648 E:11653 ||| NN
CD98  ||| S:11653 E:11668 ||| CD
heavy  ||| S:11668 E:11674 ||| JJ
chain ||| S:11674 E:11679 ||| NN
.  ||| S:11679 E:11681 ||| .
However ||| S:11681 E:11688 ||| RB
,  ||| S:11688 E:11690 ||| ,
the  ||| S:11690 E:11694 ||| DT
C109S  ||| S:11694 E:11700 ||| CD
mutant  ||| S:11700 E:11707 ||| NNS
showed  ||| S:11707 E:11714 ||| VBD
no  ||| S:11714 E:11727 ||| DT
detectable  ||| S:11727 E:11738 ||| JJ
β1  ||| S:11738 E:11741 ||| CD
association  ||| S:11741 E:11753 ||| NN
( ||| S:11753 E:11754 ||| -LRB-
Fig.  ||| S:11754 E:11759 ||| NNP
4A ||| S:11759 E:11761 ||| NNP
,  ||| S:11761 E:11763 ||| ,
right  ||| S:11763 E:11769 ||| JJ
panel ||| S:11769 E:11774 ||| NN
) ||| S:11774 E:11775 ||| -RRB-
.  ||| S:11775 E:11777 ||| .
Murine  ||| S:11777 E:11794 ||| NNP
β1  ||| S:11794 E:11797 ||| NNP
( ||| S:11797 E:11798 ||| -LRB-
Fig.  ||| S:11798 E:11803 ||| NNP
4A ||| S:11803 E:11805 ||| NNP
,  ||| S:11805 E:11807 ||| ,
left  ||| S:11807 E:11812 ||| VBN
panel ||| S:11812 E:11817 ||| NN
) ||| S:11817 E:11818 ||| -RRB-
,  ||| S:11818 E:11820 ||| ,
and  ||| S:11820 E:11824 ||| CC
mutant  ||| S:11824 E:11831 ||| NNS
and  ||| S:11831 E:11835 ||| CC
wild  ||| S:11835 E:11840 ||| JJ
type  ||| S:11840 E:11845 ||| NN
forms  ||| S:11845 E:11861 ||| NNS
of  ||| S:11861 E:11864 ||| IN
CD98  ||| S:11864 E:11869 ||| NNP
( ||| S:11869 E:11870 ||| -LRB-
see  ||| S:11870 E:11874 ||| VB
legend ||| S:11874 E:11880 ||| NN
)  ||| S:11880 E:11882 ||| -RRB-
were  ||| S:11882 E:11887 ||| VBD
expressed  ||| S:11887 E:11897 ||| VBN
at  ||| S:11897 E:11900 ||| IN
comparable  ||| S:11900 E:11911 ||| JJ
levels  ||| S:11911 E:11928 ||| NNS
in  ||| S:11928 E:11931 ||| IN
each  ||| S:11931 E:11936 ||| DT
of  ||| S:11936 E:11939 ||| IN
the  ||| S:11939 E:11943 ||| DT
transfectants ||| S:11943 E:11956 ||| NN
.  ||| S:11956 E:11958 ||| .
Notably ||| S:11958 E:11965 ||| RB
,  ||| S:11965 E:11967 ||| ,
association  ||| S:11967 E:11979 ||| NN
of  ||| S:11979 E:11992 ||| IN
CD98  ||| S:11992 E:11997 ||| CD
heavy  ||| S:11997 E:12003 ||| JJ
chain  ||| S:12003 E:12009 ||| NN
with  ||| S:12009 E:12014 ||| IN
CD98  ||| S:12014 E:12019 ||| CD
light  ||| S:12019 E:12025 ||| JJ
chain  ||| S:12025 E:12031 ||| NN
was  ||| S:12031 E:12035 ||| VBD
maintained  ||| S:12035 E:12046 ||| VBN
for  ||| S:12046 E:12060 ||| IN
the  ||| S:12060 E:12064 ||| DT
C330S  ||| S:12064 E:12070 ||| JJ
mutant ||| S:12070 E:12076 ||| NN
,  ||| S:12076 E:12078 ||| ,
but  ||| S:12078 E:12082 ||| CC
was  ||| S:12082 E:12086 ||| VBD
lost  ||| S:12086 E:12091 ||| VBN
for  ||| S:12091 E:12095 ||| IN
the  ||| S:12095 E:12099 ||| DT
C109S  ||| S:12099 E:12105 ||| CD
mutant  ||| S:12105 E:12112 ||| NNS
( ||| S:12112 E:12113 ||| -LRB-
not  ||| S:12113 E:12127 ||| RB
shown ||| S:12127 E:12132 ||| VBN
) ||| S:12132 E:12133 ||| -RRB-
,  ||| S:12133 E:12135 ||| ,
in  ||| S:12135 E:12138 ||| IN
agreement  ||| S:12138 E:12148 ||| NN
with  ||| S:12148 E:12153 ||| IN
previously  ||| S:12153 E:12164 ||| RB
published  ||| S:12164 E:12174 ||| VBN
results  ||| S:12174 E:12192 ||| NNS
suggesting  ||| S:12192 E:12203 ||| VBG
that  ||| S:12203 E:12208 ||| IN
Cysteine  ||| S:12208 E:12217 ||| NNP
109  ||| S:12217 E:12221 ||| CD
is  ||| S:12221 E:12224 ||| VBZ
required  ||| S:12224 E:12233 ||| VBN
for  ||| S:12233 E:12237 ||| IN
disulfide  ||| S:12237 E:12257 ||| JJ
linkage  ||| S:12257 E:12265 ||| NN
to  ||| S:12265 E:12268 ||| TO
the  ||| S:12268 E:12272 ||| DT
light  ||| S:12272 E:12278 ||| JJ
chain  ||| S:12278 E:12284 ||| NN
[  ||| S:12284 E:12286 ||| -LRB-
42  ||| S:12286 E:12289 ||| CD
]  ||| S:12289 E:12291 ||| -RRB-
.  ||| S:12291 E:12293 ||| .
These  ||| S:12293 E:12299 ||| DT
results  ||| S:12299 E:12307 ||| NNS
suggest  ||| S:12307 E:12325 ||| VBP
that  ||| S:12325 E:12330 ||| IN
the  ||| S:12330 E:12334 ||| DT
CD98  ||| S:12334 E:12339 ||| JJ
light  ||| S:12339 E:12345 ||| JJ
chain  ||| S:12345 E:12351 ||| NN
might  ||| S:12351 E:12357 ||| MD
be  ||| S:12357 E:12360 ||| VB
necessary  ||| S:12360 E:12370 ||| JJ
for  ||| S:12370 E:12384 ||| IN
CD98-integrin  ||| S:12384 E:12398 ||| CD
association ||| S:12398 E:12409 ||| NN
.  ||| S:12409 E:12411 ||| .
One  ||| S:12411 E:12415 ||| CD
possibility  ||| S:12415 E:12427 ||| NN
is  ||| S:12427 E:12430 ||| VBZ
that  ||| S:12430 E:12435 ||| IN
the  ||| S:12435 E:12449 ||| DT
light  ||| S:12449 E:12455 ||| JJ
chain  ||| S:12455 E:12461 ||| NN
is  ||| S:12461 E:12464 ||| VBZ
more  ||| S:12464 E:12469 ||| RBR
proximal  ||| S:12469 E:12478 ||| JJ
to  ||| S:12478 E:12481 ||| TO
the  ||| S:12481 E:12485 ||| DT
integrin ||| S:12485 E:12493 ||| NN
.  ||| S:12493 E:12495 ||| .
When  ||| S:12495 E:12510 ||| WRB
suitable  ||| S:12510 E:12519 ||| JJ
anti-light  ||| S:12519 E:12530 ||| JJ
chain  ||| S:12530 E:12536 ||| NN
reagents  ||| S:12536 E:12545 ||| NNS
become  ||| S:12545 E:12552 ||| VBP
available ||| S:12552 E:12561 ||| JJ
,  ||| S:12561 E:12563 ||| ,
this  ||| S:12563 E:12578 ||| DT
could  ||| S:12578 E:12584 ||| MD
be  ||| S:12584 E:12587 ||| VB
directly  ||| S:12587 E:12596 ||| RB
tested  ||| S:12596 E:12603 ||| VBN
in  ||| S:12603 E:12606 ||| IN
covalent  ||| S:12606 E:12615 ||| JJ
crosslinking  ||| S:12615 E:12638 ||| JJ
experiments ||| S:12638 E:12649 ||| NNS
.  ||| S:12649 E:12651 ||| .
In  ||| S:12651 E:12654 ||| IN
this  ||| S:12654 E:12659 ||| DT
regard ||| S:12659 E:12665 ||| NN
,  ||| S:12665 E:12667 ||| ,
we  ||| S:12667 E:12670 ||| PRP
have  ||| S:12670 E:12675 ||| VBP
thus  ||| S:12675 E:12680 ||| RB
far  ||| S:12680 E:12684 ||| RB
been  ||| S:12684 E:12689 ||| VBN
unable  ||| S:12689 E:12706 ||| JJ
to  ||| S:12706 E:12709 ||| TO
crosslink  ||| S:12709 E:12719 ||| CD
CD98  ||| S:12719 E:12724 ||| CD
heavy  ||| S:12724 E:12730 ||| JJ
chain  ||| S:12730 E:12736 ||| NN
directly  ||| S:12736 E:12745 ||| RB
to  ||| S:12745 E:12748 ||| TO
β1  ||| S:12748 E:12751 ||| CD
integrin ||| S:12751 E:12759 ||| NN
,  ||| S:12759 E:12771 ||| ,
using  ||| S:12771 E:12777 ||| VBG
either  ||| S:12777 E:12784 ||| DT
membrane-permeable  ||| S:12784 E:12803 ||| JJ
or  ||| S:12803 E:12806 ||| CC
membrane-impermeable  ||| S:12806 E:12837 ||| JJ
crosslinkers  ||| S:12837 E:12850 ||| NNS
( ||| S:12850 E:12851 ||| -LRB-
not  ||| S:12851 E:12855 ||| RB
shown ||| S:12855 E:12860 ||| VBN
) ||| S:12860 E:12861 ||| -RRB-
.  ||| S:12861 E:12873 ||| .
Another  ||| S:12873 E:12881 ||| DT
possibility  ||| S:12881 E:12893 ||| NN
is  ||| S:12893 E:12896 ||| VBZ
that  ||| S:12896 E:12901 ||| IN
the  ||| S:12901 E:12905 ||| DT
CD98  ||| S:12905 E:12910 ||| JJ
light  ||| S:12910 E:12916 ||| JJ
chain  ||| S:12916 E:12922 ||| NN
may  ||| S:12922 E:12936 ||| MD
target  ||| S:12936 E:12943 ||| VB
the  ||| S:12943 E:12947 ||| DT
CD98  ||| S:12947 E:12952 ||| JJ
heterodimer  ||| S:12952 E:12964 ||| NN
to  ||| S:12964 E:12967 ||| TO
the  ||| S:12967 E:12971 ||| DT
specific  ||| S:12971 E:12980 ||| JJ
membrane  ||| S:12980 E:12999 ||| JJ
domain  ||| S:12999 E:13006 ||| NN
where  ||| S:13006 E:13012 ||| WRB
interactions  ||| S:13012 E:13025 ||| NNS
with  ||| S:13025 E:13030 ||| IN
β1  ||| S:13030 E:13033 ||| CD
integrins  ||| S:13033 E:13043 ||| NNS
may  ||| S:13043 E:13047 ||| MD
be  ||| S:13047 E:13060 ||| VB
localized ||| S:13060 E:13069 ||| VBN
.  ||| S:13069 E:13071 ||| .
To  ||| S:13071 E:13074 ||| TO
test  ||| S:13074 E:13079 ||| VB
the  ||| S:13079 E:13083 ||| DT
latter  ||| S:13083 E:13090 ||| JJ
hypothesis ||| S:13090 E:13100 ||| NN
,  ||| S:13100 E:13102 ||| ,
we  ||| S:13102 E:13105 ||| PRP
compared  ||| S:13105 E:13114 ||| VBD
the  ||| S:13114 E:13128 ||| DT
total  ||| S:13128 E:13134 ||| JJ
β1  ||| S:13134 E:13137 ||| CD
integrin  ||| S:13137 E:13146 ||| JJ
distribution  ||| S:13146 E:13159 ||| NN
with  ||| S:13159 E:13164 ||| IN
the  ||| S:13164 E:13168 ||| DT
distribution  ||| S:13168 E:13181 ||| NN
of  ||| S:13181 E:13194 ||| IN
the  ||| S:13194 E:13198 ||| DT
fraction  ||| S:13198 E:13207 ||| NN
of  ||| S:13207 E:13210 ||| IN
β1  ||| S:13210 E:13213 ||| CD
integrins  ||| S:13213 E:13223 ||| JJ
complexed  ||| S:13223 E:13233 ||| NN
with  ||| S:13233 E:13238 ||| IN
CD98  ||| S:13238 E:13243 ||| CD
on  ||| S:13243 E:13246 ||| IN
HT  ||| S:13246 E:13259 ||| NNP
1080  ||| S:13259 E:13264 ||| CD
cells  ||| S:13264 E:13270 ||| NNS
( ||| S:13270 E:13271 ||| -LRB-
Fig.  ||| S:13271 E:13276 ||| NNP
4B ||| S:13276 E:13278 ||| NNP
) ||| S:13278 E:13279 ||| -RRB-
.  ||| S:13279 E:13281 ||| .
Although  ||| S:13281 E:13290 ||| IN
β1  ||| S:13290 E:13293 ||| CD
integrins  ||| S:13293 E:13303 ||| NNS
were  ||| S:13303 E:13318 ||| VBD
predominantly  ||| S:13318 E:13332 ||| RB
present  ||| S:13332 E:13340 ||| VB
in  ||| S:13340 E:13343 ||| IN
the  ||| S:13343 E:13347 ||| DT
dense  ||| S:13347 E:13353 ||| JJ
membrane  ||| S:13353 E:13362 ||| JJ
fraction  ||| S:13362 E:13371 ||| NN
on  ||| S:13371 E:13374 ||| IN
a  ||| S:13374 E:13386 ||| DT
sucrose  ||| S:13386 E:13394 ||| JJ
gradient ||| S:13394 E:13402 ||| NN
,  ||| S:13402 E:13404 ||| ,
the  ||| S:13404 E:13408 ||| DT
subset  ||| S:13408 E:13415 ||| NN
of  ||| S:13415 E:13418 ||| IN
β1  ||| S:13418 E:13421 ||| CD
integrins  ||| S:13421 E:13431 ||| JJ
complexed  ||| S:13431 E:13451 ||| NN
with  ||| S:13451 E:13456 ||| IN
CD98  ||| S:13456 E:13461 ||| NNP
was  ||| S:13461 E:13465 ||| VBD
localized  ||| S:13465 E:13475 ||| VBN
to  ||| S:13475 E:13478 ||| TO
the  ||| S:13478 E:13482 ||| DT
' ||| S:13482 E:13483 ||| POS
light ||| S:13483 E:13488 ||| NN
'  ||| S:13488 E:13490 ||| POS
membrane  ||| S:13490 E:13509 ||| JJ
fractions ||| S:13509 E:13518 ||| NNS
.  ||| S:13518 E:13520 ||| .
These  ||| S:13520 E:13526 ||| DT
fractions  ||| S:13526 E:13536 ||| NN
typically  ||| S:13536 E:13546 ||| RB
contain  ||| S:13546 E:13554 ||| VB
caveolae  ||| S:13554 E:13563 ||| JJ
and  ||| S:13563 E:13577 ||| NN
' ||| S:13577 E:13578 ||| POS
membrane  ||| S:13578 E:13587 ||| JJ
rafts ||| S:13587 E:13592 ||| NN
'  ||| S:13592 E:13594 ||| POS
thought  ||| S:13594 E:13602 ||| NN
to  ||| S:13602 E:13605 ||| TO
be  ||| S:13605 E:13608 ||| VB
enriched  ||| S:13608 E:13617 ||| VBN
in  ||| S:13617 E:13620 ||| IN
active  ||| S:13620 E:13637 ||| JJ
signaling  ||| S:13637 E:13647 ||| JJ
complexes  ||| S:13647 E:13657 ||| NNS
[  ||| S:13657 E:13659 ||| -LRB-
34  ||| S:13659 E:13662 ||| CD
35  ||| S:13662 E:13665 ||| CD
43  ||| S:13665 E:13668 ||| CD
]  ||| S:13668 E:13670 ||| -RRB-
.  ||| S:13670 E:13672 ||| .
The  ||| S:13672 E:13676 ||| DT
fraction  ||| S:13676 E:13685 ||| NN
of  ||| S:13685 E:13688 ||| IN
the  ||| S:13688 E:13692 ||| DT
β1  ||| S:13692 E:13705 ||| NNP
integrins  ||| S:13705 E:13715 ||| VBD
detected  ||| S:13715 E:13724 ||| VBN
in  ||| S:13724 E:13727 ||| IN
the  ||| S:13727 E:13731 ||| DT
light  ||| S:13731 E:13737 ||| JJ
membrane  ||| S:13737 E:13746 ||| JJ
fractions  ||| S:13746 E:13766 ||| NN
represents  ||| S:13766 E:13777 ||| VBZ
no  ||| S:13777 E:13780 ||| DT
more  ||| S:13780 E:13785 ||| JJR
than  ||| S:13785 E:13790 ||| IN
5 ||| S:13790 E:13791 ||| CD
%  ||| S:13791 E:13793 ||| NN
of  ||| S:13793 E:13796 ||| IN
total  ||| S:13796 E:13802 ||| JJ
β1  ||| S:13802 E:13805 ||| CD
integrins  ||| S:13805 E:13815 ||| NNS
( ||| S:13815 E:13816 ||| -LRB-
based  ||| S:13816 E:13832 ||| VBN
on  ||| S:13832 E:13835 ||| IN
the  ||| S:13835 E:13839 ||| DT
densitometric  ||| S:13839 E:13853 ||| JJ
analysis ||| S:13853 E:13861 ||| NN
,  ||| S:13861 E:13863 ||| ,
not  ||| S:13863 E:13867 ||| RB
shown ||| S:13867 E:13872 ||| VBN
) ||| S:13872 E:13873 ||| -RRB-
.  ||| S:13873 E:13875 ||| .
Though  ||| S:13875 E:13892 ||| IN
caveolin  ||| S:13892 E:13901 ||| NN
is  ||| S:13901 E:13904 ||| VBZ
present  ||| S:13904 E:13912 ||| JJ
in  ||| S:13912 E:13915 ||| IN
the  ||| S:13915 E:13919 ||| DT
same  ||| S:13919 E:13924 ||| JJ
fractions  ||| S:13924 E:13934 ||| NNS
as  ||| S:13934 E:13947 ||| IN
CD98-integrin  ||| S:13947 E:13961 ||| CD
complexes ||| S:13961 E:13970 ||| NNS
,  ||| S:13970 E:13972 ||| ,
it  ||| S:13972 E:13975 ||| PRP
does  ||| S:13975 E:13980 ||| VBZ
not  ||| S:13980 E:13984 ||| RB
co-immunoprecipitate  ||| S:13984 E:14015 ||| JJ
with  ||| S:14015 E:14020 ||| IN
CD98  ||| S:14020 E:14025 ||| CD
under  ||| S:14025 E:14031 ||| IN
these  ||| S:14031 E:14037 ||| DT
conditions  ||| S:14037 E:14048 ||| NNS
( ||| S:14048 E:14049 ||| -LRB-
not  ||| S:14049 E:14053 ||| RB
shown ||| S:14053 E:14058 ||| VBN
)  ||| S:14058 E:14060 ||| -RRB-
and  ||| S:14060 E:14064 ||| CC
thus  ||| S:14064 E:14069 ||| RB
is  ||| S:14069 E:14082 ||| VBZ
not  ||| S:14082 E:14086 ||| RB
part  ||| S:14086 E:14091 ||| NN
of  ||| S:14091 E:14094 ||| IN
integrin-CD98  ||| S:14094 E:14108 ||| CD
complexes ||| S:14108 E:14117 ||| NNS
.  ||| S:14117 E:14119 ||| .
Similarly ||| S:14119 E:14128 ||| RB
,  ||| S:14128 E:14140 ||| ,
GPI-linked  ||| S:14140 E:14151 ||| JJ
proteins  ||| S:14151 E:14160 ||| NNS
such  ||| S:14160 E:14165 ||| JJ
as  ||| S:14165 E:14168 ||| IN
CD  ||| S:14168 E:14171 ||| NNP
109 ||| S:14171 E:14174 ||| CD
,  ||| S:14174 E:14176 ||| ,
TM4SF  ||| S:14176 E:14182 ||| CD
proteins  ||| S:14182 E:14191 ||| NNS
such  ||| S:14191 E:14206 ||| JJ
as  ||| S:14206 E:14209 ||| IN
CD81 ||| S:14209 E:14213 ||| NNP
,  ||| S:14213 E:14215 ||| ,
and  ||| S:14215 E:14219 ||| CC
other  ||| S:14219 E:14225 ||| JJ
transmembrane  ||| S:14225 E:14239 ||| JJ
proteins  ||| S:14239 E:14248 ||| NNS
such  ||| S:14248 E:14253 ||| JJ
as  ||| S:14253 E:14266 ||| IN
CD147 ||| S:14266 E:14271 ||| NNP
/ ||| S:14271 E:14272 ||| NNP
EMMPRIN  ||| S:14272 E:14280 ||| NNP
can  ||| S:14280 E:14284 ||| MD
be  ||| S:14284 E:14287 ||| VB
found  ||| S:14287 E:14293 ||| VBN
at  ||| S:14293 E:14296 ||| IN
substantial  ||| S:14296 E:14308 ||| JJ
levels  ||| S:14308 E:14315 ||| NNS
in  ||| S:14315 E:14318 ||| IN
light  ||| S:14318 E:14334 ||| JJ
membrane  ||| S:14334 E:14343 ||| JJ
fractions  ||| S:14343 E:14353 ||| NNS
[  ||| S:14353 E:14355 ||| -LRB-
44  ||| S:14355 E:14358 ||| CD
45  ||| S:14358 E:14361 ||| CD
]  ||| S:14361 E:14363 ||| -RRB-
,  ||| S:14363 E:14365 ||| ,
and  ||| S:14365 E:14369 ||| CC
our  ||| S:14369 E:14373 ||| PRP$
unpublished  ||| S:14373 E:14395 ||| JJ
results ||| S:14395 E:14402 ||| NNS
) ||| S:14402 E:14403 ||| -RRB-
,  ||| S:14403 E:14405 ||| ,
and  ||| S:14405 E:14409 ||| CC
these  ||| S:14409 E:14415 ||| DT
also  ||| S:14415 E:14420 ||| RB
did  ||| S:14420 E:14424 ||| VBD
not  ||| S:14424 E:14428 ||| RB
co-immunoprecipitate  ||| S:14428 E:14459 ||| JJ
with  ||| S:14459 E:14464 ||| IN
CD98  ||| S:14464 E:14469 ||| NNP
( ||| S:14469 E:14470 ||| -LRB-
Fig.  ||| S:14470 E:14475 ||| NNP
2A ||| S:14475 E:14477 ||| NNP
,  ||| S:14477 E:14479 ||| ,
2B ||| S:14479 E:14481 ||| CD
) ||| S:14481 E:14482 ||| -RRB-
.  ||| S:14482 E:14484 ||| .
Thus ||| S:14484 E:14488 ||| RB
,  ||| S:14488 E:14490 ||| ,
CD98  ||| S:14490 E:14495 ||| CD
association  ||| S:14495 E:14507 ||| NN
with  ||| S:14507 E:14522 ||| IN
integrin  ||| S:14522 E:14531 ||| NN
has  ||| S:14531 E:14535 ||| VBZ
another  ||| S:14535 E:14543 ||| DT
level  ||| S:14543 E:14549 ||| NN
of  ||| S:14549 E:14552 ||| IN
specificity  ||| S:14552 E:14564 ||| NN
beyond  ||| S:14564 E:14571 ||| IN
simply  ||| S:14571 E:14588 ||| RB
co-localizing  ||| S:14588 E:14602 ||| JJ
in  ||| S:14602 E:14605 ||| IN
light  ||| S:14605 E:14611 ||| JJ
membrane  ||| S:14611 E:14620 ||| JJ
fractions ||| S:14620 E:14629 ||| NNS
.  ||| S:14629 E:14641 ||| .
Finally ||| S:14641 E:14648 ||| RB
,  ||| S:14648 E:14650 ||| ,
to  ||| S:14650 E:14653 ||| TO
see  ||| S:14653 E:14657 ||| VB
whether  ||| S:14657 E:14665 ||| IN
the  ||| S:14665 E:14669 ||| DT
CD98  ||| S:14669 E:14674 ||| JJ
light  ||| S:14674 E:14680 ||| JJ
chain  ||| S:14680 E:14686 ||| NN
might  ||| S:14686 E:14702 ||| MD
help  ||| S:14702 E:14707 ||| VB
to  ||| S:14707 E:14710 ||| TO
target  ||| S:14710 E:14717 ||| VB
the  ||| S:14717 E:14721 ||| DT
CD98  ||| S:14721 E:14726 ||| JJ
heavy  ||| S:14726 E:14732 ||| JJ
chain  ||| S:14732 E:14738 ||| NN
to  ||| S:14738 E:14741 ||| TO
the  ||| S:14741 E:14745 ||| DT
light  ||| S:14745 E:14751 ||| JJ
membrane  ||| S:14751 E:14770 ||| JJ
fractions ||| S:14770 E:14779 ||| NNS
,  ||| S:14779 E:14781 ||| ,
we  ||| S:14781 E:14784 ||| PRP
looked  ||| S:14784 E:14791 ||| VBD
at  ||| S:14791 E:14794 ||| IN
the  ||| S:14794 E:14798 ||| DT
distribution  ||| S:14798 E:14811 ||| NN
of  ||| S:14811 E:14814 ||| IN
the  ||| S:14814 E:14818 ||| DT
wild  ||| S:14818 E:14823 ||| JJ
type  ||| S:14823 E:14838 ||| NN
CD98  ||| S:14838 E:14843 ||| NN
and  ||| S:14843 E:14847 ||| CC
CD98  ||| S:14847 E:14852 ||| CD
mutants  ||| S:14852 E:14860 ||| NN
in  ||| S:14860 E:14863 ||| IN
the  ||| S:14863 E:14867 ||| DT
sucrose  ||| S:14867 E:14875 ||| JJ
gradients  ||| S:14875 E:14885 ||| NNS
( ||| S:14885 E:14886 ||| -LRB-
Fig.  ||| S:14886 E:14901 ||| NNP
4C ||| S:14901 E:14903 ||| NNP
, ||| S:14903 E:14904 ||| ,
D ||| S:14904 E:14905 ||| NNP
) ||| S:14905 E:14906 ||| -RRB-
.  ||| S:14906 E:14908 ||| .
The  ||| S:14908 E:14912 ||| DT
majority  ||| S:14912 E:14921 ||| NN
of  ||| S:14921 E:14924 ||| IN
wild  ||| S:14924 E:14929 ||| JJ
type  ||| S:14929 E:14934 ||| NN
CD98  ||| S:14934 E:14939 ||| CD
heavy  ||| S:14939 E:14945 ||| JJ
chain  ||| S:14945 E:14951 ||| NN
and  ||| S:14951 E:14965 ||| CC
control  ||| S:14965 E:14973 ||| NN
mutant  ||| S:14973 E:14980 ||| NNS
( ||| S:14980 E:14981 ||| -LRB-
C330S ||| S:14981 E:14986 ||| NNP
)  ||| S:14986 E:14988 ||| -RRB-
are  ||| S:14988 E:14992 ||| VBP
localized  ||| S:14992 E:15002 ||| VBN
to  ||| S:15002 E:15005 ||| TO
the  ||| S:15005 E:15009 ||| DT
light  ||| S:15009 E:15025 ||| JJ
membrane  ||| S:15025 E:15034 ||| JJ
fraction  ||| S:15034 E:15043 ||| NN
( ||| S:15043 E:15044 ||| -LRB-
55-60 ||| S:15044 E:15049 ||| NNP
% ||| S:15049 E:15050 ||| NN
,  ||| S:15050 E:15052 ||| ,
Fig.  ||| S:15052 E:15057 ||| CD
4D ||| S:15057 E:15059 ||| CD
) ||| S:15059 E:15060 ||| -RRB-
,  ||| S:15060 E:15062 ||| ,
whereas  ||| S:15062 E:15070 ||| IN
the  ||| S:15070 E:15074 ||| DT
C109S  ||| S:15074 E:15090 ||| JJ
mutant  ||| S:15090 E:15097 ||| NN
is  ||| S:15097 E:15100 ||| VBZ
partially  ||| S:15100 E:15110 ||| RB
shifted  ||| S:15110 E:15118 ||| VBN
to  ||| S:15118 E:15121 ||| TO
the  ||| S:15121 E:15125 ||| DT
dense  ||| S:15125 E:15131 ||| JJ
fractions  ||| S:15131 E:15141 ||| NNS
( ||| S:15141 E:15142 ||| -LRB-
40 ||| S:15142 E:15144 ||| CD
%  ||| S:15144 E:15156 ||| NN
in  ||| S:15156 E:15159 ||| IN
the  ||| S:15159 E:15163 ||| DT
light  ||| S:15163 E:15169 ||| JJ
fraction ||| S:15169 E:15177 ||| NN
,  ||| S:15177 E:15179 ||| ,
50 ||| S:15179 E:15181 ||| CD
%  ||| S:15181 E:15183 ||| NN
in  ||| S:15183 E:15186 ||| IN
the  ||| S:15186 E:15190 ||| DT
dense  ||| S:15190 E:15196 ||| JJ
fractions ||| S:15196 E:15205 ||| NNS
,  ||| S:15205 E:15207 ||| ,
Fig.  ||| S:15207 E:15222 ||| CD
4D ||| S:15222 E:15224 ||| CD
) ||| S:15224 E:15225 ||| -RRB-
.  ||| S:15225 E:15227 ||| .
These  ||| S:15227 E:15233 ||| DT
results  ||| S:15233 E:15241 ||| NNS
are  ||| S:15241 E:15245 ||| VBP
consistent  ||| S:15245 E:15256 ||| JJ
with  ||| S:15256 E:15261 ||| IN
the  ||| S:15261 E:15265 ||| DT
CD98  ||| S:15265 E:15270 ||| JJ
light  ||| S:15270 E:15286 ||| JJ
chain  ||| S:15286 E:15292 ||| NN
targeting  ||| S:15292 E:15302 ||| VBG
the  ||| S:15302 E:15306 ||| DT
CD98  ||| S:15306 E:15311 ||| JJ
heavy  ||| S:15311 E:15317 ||| JJ
chain  ||| S:15317 E:15323 ||| NN
to  ||| S:15323 E:15326 ||| TO
light  ||| S:15326 E:15332 ||| VB
membrane  ||| S:15332 E:15351 ||| JJ
fractions ||| S:15351 E:15360 ||| NNS
.  ||| S:15360 E:15362 ||| .
It  ||| S:15362 E:15365 ||| PRP
is  ||| S:15365 E:15368 ||| VBZ
perhaps  ||| S:15368 E:15376 ||| RB
not  ||| S:15376 E:15380 ||| RB
surprising  ||| S:15380 E:15391 ||| JJ
to  ||| S:15391 E:15394 ||| TO
observe  ||| S:15394 E:15402 ||| VB
~40 ||| S:15402 E:15405 ||| CD
%  ||| S:15405 E:15417 ||| NN
of  ||| S:15417 E:15420 ||| IN
the  ||| S:15420 E:15424 ||| DT
C109S  ||| S:15424 E:15430 ||| JJ
heavy  ||| S:15430 E:15436 ||| JJ
chain  ||| S:15436 E:15442 ||| NN
mutant  ||| S:15442 E:15449 ||| VBZ
remaining  ||| S:15449 E:15459 ||| VBG
in  ||| S:15459 E:15462 ||| IN
the  ||| S:15462 E:15466 ||| DT
light  ||| S:15466 E:15482 ||| JJ
membrane  ||| S:15482 E:15491 ||| JJ
fraction  ||| S:15491 E:15500 ||| NN
( ||| S:15500 E:15501 ||| -LRB-
Fig.  ||| S:15501 E:15506 ||| NNP
4C ||| S:15506 E:15508 ||| NNP
, ||| S:15508 E:15509 ||| ,
D ||| S:15509 E:15510 ||| NNP
) ||| S:15510 E:15511 ||| -RRB-
,  ||| S:15511 E:15513 ||| ,
considering  ||| S:15513 E:15525 ||| VBG
that  ||| S:15525 E:15530 ||| IN
the  ||| S:15530 E:15534 ||| DT
CD98  ||| S:15534 E:15549 ||| JJ
heterodimer  ||| S:15549 E:15561 ||| NN
retains  ||| S:15561 E:15569 ||| VBZ
partial  ||| S:15569 E:15577 ||| JJ
association  ||| S:15577 E:15589 ||| NN
and  ||| S:15589 E:15593 ||| CC
amino  ||| S:15593 E:15599 ||| JJ
acid  ||| S:15599 E:15614 ||| NN
transport  ||| S:15614 E:15624 ||| NN
function  ||| S:15624 E:15633 ||| NN
even  ||| S:15633 E:15638 ||| RB
in  ||| S:15638 E:15641 ||| IN
the  ||| S:15641 E:15645 ||| DT
absence  ||| S:15645 E:15653 ||| NN
of  ||| S:15653 E:15656 ||| IN
a  ||| S:15656 E:15658 ||| DT
disulfide  ||| S:15658 E:15678 ||| JJ
linkage  ||| S:15678 E:15686 ||| NN
of  ||| S:15686 E:15689 ||| IN
the  ||| S:15689 E:15693 ||| DT
subunits  ||| S:15693 E:15702 ||| NN
[  ||| S:15702 E:15704 ||| -LRB-
42  ||| S:15704 E:15707 ||| CD
]  ||| S:15707 E:15709 ||| -RRB-
.  ||| S:15709 E:15711 ||| .
Notably ||| S:15711 E:15718 ||| RB
,  ||| S:15718 E:15720 ||| ,
transformation  ||| S:15720 E:15745 ||| NN
of  ||| S:15745 E:15748 ||| IN
BALB  ||| S:15748 E:15753 ||| NNP
3T3  ||| S:15753 E:15757 ||| NNP
cells  ||| S:15757 E:15763 ||| NNS
caused  ||| S:15763 E:15770 ||| VBN
by  ||| S:15770 E:15773 ||| IN
over-expression  ||| S:15773 E:15789 ||| JJ
of  ||| S:15789 E:15792 ||| IN
CD98  ||| S:15792 E:15797 ||| CD
heavy  ||| S:15797 E:15813 ||| JJ
chain  ||| S:15813 E:15819 ||| NN
required  ||| S:15819 E:15828 ||| VBD
its  ||| S:15828 E:15832 ||| PRP$
association  ||| S:15832 E:15844 ||| NN
with  ||| S:15844 E:15849 ||| IN
the  ||| S:15849 E:15853 ||| DT
light  ||| S:15853 E:15859 ||| JJ
chain ||| S:15859 E:15864 ||| NN
,  ||| S:15864 E:15866 ||| ,
and  ||| S:15866 E:15880 ||| CC
a  ||| S:15880 E:15882 ||| DT
missense  ||| S:15882 E:15891 ||| JJ
mutation  ||| S:15891 E:15900 ||| NN
in  ||| S:15900 E:15903 ||| IN
C109  ||| S:15903 E:15908 ||| NNP
eliminated  ||| S:15908 E:15919 ||| VBD
its  ||| S:15919 E:15923 ||| PRP$
transforming  ||| S:15923 E:15946 ||| JJ
activity  ||| S:15946 E:15955 ||| NN
[  ||| S:15955 E:15957 ||| -LRB-
10  ||| S:15957 E:15960 ||| CD
]  ||| S:15960 E:15962 ||| -RRB-
.  ||| S:15962 E:15974 ||| .
The  ||| S:15974 E:15978 ||| DT
CD98  ||| S:15978 E:15983 ||| JJ
protein  ||| S:15983 E:15991 ||| NN
was  ||| S:15991 E:15995 ||| VBD
recently  ||| S:15995 E:16004 ||| RB
shown  ||| S:16004 E:16010 ||| VBN
to  ||| S:16010 E:16013 ||| TO
associate  ||| S:16013 E:16033 ||| VB
specifically  ||| S:16033 E:16046 ||| RB
with  ||| S:16046 E:16051 ||| IN
integrin  ||| S:16051 E:16060 ||| FW
β  ||| S:16060 E:16062 ||| FW
chain  ||| S:16062 E:16068 ||| FW
cytoplasmic  ||| S:16068 E:16080 ||| FW
tail  ||| S:16080 E:16095 ||| FW
fusion  ||| S:16095 E:16102 ||| FW
proteins  ||| S:16102 E:16111 ||| FW
[  ||| S:16111 E:16113 ||| -LRB-
29  ||| S:16113 E:16116 ||| CD
]  ||| S:16116 E:16118 ||| -RRB-
in  ||| S:16118 E:16121 ||| IN
0.05 ||| S:16121 E:16125 ||| CD
%  ||| S:16125 E:16127 ||| NN
Triton  ||| S:16127 E:16134 ||| NNP
X-100  ||| S:16134 E:16140 ||| NNP
detergent  ||| S:16140 E:16160 ||| NN
conditions ||| S:16160 E:16170 ||| NNS
.  ||| S:16170 E:16172 ||| .
One  ||| S:16172 E:16176 ||| PRP
may  ||| S:16176 E:16180 ||| MD
speculate  ||| S:16180 E:16190 ||| VB
that  ||| S:16190 E:16195 ||| IN
the  ||| S:16195 E:16199 ||| DT
use  ||| S:16199 E:16203 ||| NN
of  ||| S:16203 E:16206 ||| IN
0.05 ||| S:16206 E:16210 ||| CD
%  ||| S:16210 E:16222 ||| NN
Triton  ||| S:16222 E:16229 ||| NNP
X-100  ||| S:16229 E:16235 ||| NNP
may  ||| S:16235 E:16239 ||| MD
have  ||| S:16239 E:16244 ||| VB
allowed  ||| S:16244 E:16252 ||| VBN
maintenance  ||| S:16252 E:16264 ||| NN
of  ||| S:16264 E:16267 ||| IN
CD98  ||| S:16267 E:16282 ||| CD
microdomains ||| S:16282 E:16294 ||| NN
,  ||| S:16294 E:16296 ||| ,
needed  ||| S:16296 E:16303 ||| VBN
for  ||| S:16303 E:16307 ||| IN
β1  ||| S:16307 E:16310 ||| CD
interaction ||| S:16310 E:16321 ||| NNS
.  ||| S:16321 E:16323 ||| .
In  ||| S:16323 E:16326 ||| IN
this  ||| S:16326 E:16331 ||| DT
regard ||| S:16331 E:16337 ||| NN
,  ||| S:16337 E:16349 ||| ,
in  ||| S:16349 E:16352 ||| IN
0.05 ||| S:16352 E:16356 ||| CD
%  ||| S:16356 E:16358 ||| NN
Triton  ||| S:16358 E:16365 ||| NNP
X-100  ||| S:16365 E:16371 ||| NNP
lysates ||| S:16371 E:16378 ||| NN
,  ||| S:16378 E:16380 ||| ,
many  ||| S:16380 E:16385 ||| JJ
transmembrane  ||| S:16385 E:16409 ||| JJ
proteins  ||| S:16409 E:16418 ||| NNS
remain  ||| S:16418 E:16425 ||| VBP
in  ||| S:16425 E:16428 ||| IN
the  ||| S:16428 E:16432 ||| DT
light  ||| S:16432 E:16438 ||| JJ
membrane  ||| S:16438 E:16447 ||| JJ
fractions  ||| S:16447 E:16457 ||| NNS
of  ||| S:16457 E:16460 ||| IN
a  ||| S:16460 E:16472 ||| DT
sucrose  ||| S:16472 E:16480 ||| JJ
gradient  ||| S:16480 E:16489 ||| NNS
[  ||| S:16489 E:16491 ||| -LRB-
46  ||| S:16491 E:16494 ||| CD
47  ||| S:16494 E:16497 ||| CD
]  ||| S:16497 E:16499 ||| -RRB-
.  ||| S:16499 E:16501 ||| .
Although  ||| S:16501 E:16510 ||| IN
the  ||| S:16510 E:16514 ||| DT
role  ||| S:16514 E:16519 ||| NN
of  ||| S:16519 E:16522 ||| IN
the  ||| S:16522 E:16536 ||| DT
CD98  ||| S:16536 E:16541 ||| JJ
light  ||| S:16541 E:16547 ||| JJ
chain  ||| S:16547 E:16553 ||| NN
was  ||| S:16553 E:16557 ||| VBD
not  ||| S:16557 E:16561 ||| RB
addressed  ||| S:16561 E:16571 ||| VBN
in  ||| S:16571 E:16574 ||| IN
the  ||| S:16574 E:16578 ||| DT
earlier  ||| S:16578 E:16586 ||| JJR
study  ||| S:16586 E:16592 ||| NN
[  ||| S:16592 E:16604 ||| -LRB-
29  ||| S:16604 E:16607 ||| CD
]  ||| S:16607 E:16609 ||| -RRB-
,  ||| S:16609 E:16611 ||| ,
we  ||| S:16611 E:16614 ||| PRP
assume  ||| S:16614 E:16621 ||| VBP
that  ||| S:16621 E:16626 ||| IN
it  ||| S:16626 E:16629 ||| PRP
may  ||| S:16629 E:16633 ||| MD
have  ||| S:16633 E:16638 ||| VB
played  ||| S:16638 E:16645 ||| VBN
a  ||| S:16645 E:16647 ||| DT
key  ||| S:16647 E:16651 ||| JJ
role ||| S:16651 E:16655 ||| NN
.  ||| S:16655 E:16667 ||| .
Furthermore ||| S:16667 E:16678 ||| RB
,  ||| S:16678 E:16680 ||| ,
CD98  ||| S:16680 E:16685 ||| CD
interaction  ||| S:16685 E:16697 ||| NN
with  ||| S:16697 E:16702 ||| IN
recombinant  ||| S:16702 E:16714 ||| JJ
β  ||| S:16714 E:16716 ||| JJ
chain  ||| S:16716 E:16732 ||| NN
cytoplasmic  ||| S:16732 E:16744 ||| NN
tail  ||| S:16744 E:16749 ||| NN
fusion  ||| S:16749 E:16756 ||| NN
proteins ||| S:16756 E:16764 ||| NNS
,  ||| S:16764 E:16766 ||| ,
in  ||| S:16766 E:16769 ||| IN
the  ||| S:16769 E:16773 ||| DT
absence  ||| S:16773 E:16781 ||| NN
of  ||| S:16781 E:16784 ||| IN
the  ||| S:16784 E:16788 ||| DT
α  ||| S:16788 E:16800 ||| JJ
chain  ||| S:16800 E:16806 ||| NN
[  ||| S:16806 E:16808 ||| -LRB-
29  ||| S:16808 E:16811 ||| CD
]  ||| S:16811 E:16813 ||| -RRB-
,  ||| S:16813 E:16815 ||| ,
is  ||| S:16815 E:16818 ||| VBZ
consistent  ||| S:16818 E:16829 ||| JJ
with  ||| S:16829 E:16834 ||| IN
our  ||| S:16834 E:16838 ||| PRP$
observation  ||| S:16838 E:16850 ||| NN
that  ||| S:16850 E:16865 ||| IN
the  ||| S:16865 E:16869 ||| DT
α  ||| S:16869 E:16871 ||| JJ
chain  ||| S:16871 E:16877 ||| NN
cytoplasmic  ||| S:16877 E:16889 ||| NN
tail  ||| S:16889 E:16894 ||| NN
is  ||| S:16894 E:16897 ||| VBZ
not  ||| S:16897 E:16901 ||| RB
needed  ||| S:16901 E:16908 ||| VBN
for  ||| S:16908 E:16922 ||| IN
integrin-CD98  ||| S:16922 E:16936 ||| CD
association ||| S:16936 E:16947 ||| NN
.  ||| S:16947 E:16949 ||| .
On  ||| S:16949 E:16952 ||| IN
the  ||| S:16952 E:16956 ||| DT
other  ||| S:16956 E:16962 ||| JJ
hand ||| S:16962 E:16966 ||| NN
,  ||| S:16966 E:16968 ||| ,
we  ||| S:16968 E:16971 ||| PRP
observed  ||| S:16971 E:16990 ||| VBD
CD98  ||| S:16990 E:16995 ||| CD
interaction  ||| S:16995 E:17007 ||| NN
with  ||| S:17007 E:17012 ||| IN
several  ||| S:17012 E:17020 ||| JJ
β1  ||| S:17020 E:17023 ||| CD
integrins ||| S:17023 E:17032 ||| NN
,  ||| S:17032 E:17034 ||| ,
but  ||| S:17034 E:17038 ||| CC
not  ||| S:17038 E:17042 ||| RB
α4β1 ||| S:17042 E:17046 ||| CD
.  ||| S:17046 E:17058 ||| .
Thus  ||| S:17058 E:17063 ||| RB
for  ||| S:17063 E:17067 ||| IN
intact  ||| S:17067 E:17074 ||| JJ
integrins  ||| S:17074 E:17084 ||| NN
in  ||| S:17084 E:17087 ||| IN
the  ||| S:17087 E:17091 ||| DT
context  ||| S:17091 E:17099 ||| NN
of  ||| S:17099 E:17102 ||| IN
mammalian  ||| S:17102 E:17122 ||| JJ
cells ||| S:17122 E:17127 ||| NNS
,  ||| S:17127 E:17129 ||| ,
the  ||| S:17129 E:17133 ||| DT
integrin  ||| S:17133 E:17142 ||| JJ
β  ||| S:17142 E:17144 ||| JJ
chain  ||| S:17144 E:17150 ||| NN
apparently  ||| S:17150 E:17161 ||| RB
does  ||| S:17161 E:17166 ||| VBZ
contribute  ||| S:17166 E:17177 ||| VBN
to  ||| S:17177 E:17190 ||| TO
the  ||| S:17190 E:17194 ||| DT
specificity  ||| S:17194 E:17206 ||| NN
of  ||| S:17206 E:17209 ||| IN
CD98  ||| S:17209 E:17214 ||| CD
interaction ||| S:17214 E:17225 ||| NNS
.  ||| S:17225 E:17227 ||| .
The  ||| S:17227 E:17231 ||| DT
α  ||| S:17231 E:17233 ||| JJ
chain  ||| S:17233 E:17239 ||| NN
might  ||| S:17239 E:17255 ||| MD
provide  ||| S:17255 E:17263 ||| VB
a  ||| S:17263 E:17265 ||| DT
level  ||| S:17265 E:17271 ||| NN
of  ||| S:17271 E:17274 ||| IN
specificity  ||| S:17274 E:17286 ||| NN
by  ||| S:17286 E:17289 ||| IN
changing  ||| S:17289 E:17298 ||| VBG
the  ||| S:17298 E:17312 ||| DT
conformation  ||| S:17312 E:17325 ||| NN
of  ||| S:17325 E:17328 ||| IN
the  ||| S:17328 E:17332 ||| DT
β  ||| S:17332 E:17334 ||| JJ
chain  ||| S:17334 E:17340 ||| NN
and ||| S:17340 E:17343 ||| CC
/ ||| S:17343 E:17344 ||| NNP
or  ||| S:17344 E:17347 ||| CC
by  ||| S:17347 E:17350 ||| IN
providing  ||| S:17350 E:17360 ||| VBG
an  ||| S:17360 E:17373 ||| DT
additional  ||| S:17373 E:17384 ||| JJ
site  ||| S:17384 E:17389 ||| NN
of  ||| S:17389 E:17392 ||| IN
interaction  ||| S:17392 E:17404 ||| NN
with  ||| S:17404 E:17409 ||| IN
the  ||| S:17409 E:17413 ||| DT
CD98  ||| S:17413 E:17418 ||| JJ
light  ||| S:17418 E:17424 ||| NN
or  ||| S:17424 E:17437 ||| CC
heavy  ||| S:17437 E:17443 ||| JJ
chains ||| S:17443 E:17449 ||| NNS
.  ||| S:17449 E:17461 ||| .
Because  ||| S:17461 E:17469 ||| IN
our  ||| S:17469 E:17473 ||| PRP$
integrin-CD98  ||| S:17473 E:17487 ||| JJ
complex  ||| S:17487 E:17495 ||| NN
was  ||| S:17495 E:17499 ||| VBD
observed  ||| S:17499 E:17508 ||| VBN
in  ||| S:17508 E:17521 ||| IN
light  ||| S:17521 E:17527 ||| JJ
membrane  ||| S:17527 E:17536 ||| JJ
fractions  ||| S:17536 E:17546 ||| NNS
and  ||| S:17546 E:17550 ||| CC
not  ||| S:17550 E:17554 ||| RB
in  ||| S:17554 E:17557 ||| IN
dense  ||| S:17557 E:17563 ||| FW
sucrose  ||| S:17563 E:17581 ||| FW
gradient  ||| S:17581 E:17590 ||| FW
fractions ||| S:17590 E:17599 ||| FW
,  ||| S:17599 E:17601 ||| ,
and  ||| S:17601 E:17605 ||| CC
because  ||| S:17605 E:17613 ||| IN
we  ||| S:17613 E:17616 ||| PRP
could  ||| S:17616 E:17622 ||| MD
not  ||| S:17622 E:17626 ||| RB
capture  ||| S:17626 E:17634 ||| VB
the  ||| S:17634 E:17648 ||| DT
complex  ||| S:17648 E:17656 ||| NN
by  ||| S:17656 E:17659 ||| IN
covalent  ||| S:17659 E:17668 ||| JJ
crosslinking  ||| S:17668 E:17681 ||| NNS
( ||| S:17681 E:17682 ||| -LRB-
not  ||| S:17682 E:17686 ||| RB
shown ||| S:17686 E:17691 ||| VBN
) ||| S:17691 E:17692 ||| -RRB-
,  ||| S:17692 E:17694 ||| ,
the  ||| S:17694 E:17708 ||| DT
interaction  ||| S:17708 E:17720 ||| NN
may  ||| S:17720 E:17724 ||| MD
not  ||| S:17724 E:17728 ||| RB
be  ||| S:17728 E:17731 ||| VB
direct ||| S:17731 E:17737 ||| JJ
.  ||| S:17737 E:17739 ||| .
Nonetheless ||| S:17739 E:17750 ||| RB
,  ||| S:17750 E:17752 ||| ,
an  ||| S:17752 E:17755 ||| DT
abundance  ||| S:17755 E:17775 ||| NN
of  ||| S:17775 E:17778 ||| IN
evidence  ||| S:17778 E:17787 ||| NN
points  ||| S:17787 E:17794 ||| NNS
to  ||| S:17794 E:17797 ||| TO
the  ||| S:17797 E:17801 ||| DT
functional  ||| S:17801 E:17812 ||| JJ
relevance  ||| S:17812 E:17822 ||| NN
of  ||| S:17822 E:17825 ||| IN
this  ||| S:17825 E:17840 ||| DT
complex  ||| S:17840 E:17848 ||| JJ
( ||| S:17848 E:17849 ||| -LRB-
references  ||| S:17849 E:17860 ||| NNS
above ||| S:17860 E:17865 ||| IN
) ||| S:17865 E:17866 ||| -RRB-
.  ||| S:17866 E:17868 ||| .
Furthermore ||| S:17868 E:17879 ||| RB
,  ||| S:17879 E:17881 ||| ,
integrin  ||| S:17881 E:17900 ||| CD
αVβ3-CD47  ||| S:17900 E:17910 ||| CD
complexes  ||| S:17910 E:17920 ||| NNS
have  ||| S:17920 E:17925 ||| VBP
considerable  ||| S:17925 E:17938 ||| JJ
functional  ||| S:17938 E:17959 ||| JJ
relevance ||| S:17959 E:17968 ||| NN
,  ||| S:17968 E:17970 ||| ,
despite  ||| S:17970 E:17978 ||| IN
being  ||| S:17978 E:17984 ||| VBG
found  ||| S:17984 E:17990 ||| VBN
only  ||| S:17990 E:17995 ||| RB
under  ||| S:17995 E:18001 ||| IN
relatively  ||| S:18001 E:18012 ||| RB
mild  ||| S:18012 E:18027 ||| JJ
detergent  ||| S:18027 E:18037 ||| NN
conditions  ||| S:18037 E:18048 ||| NNS
( ||| S:18048 E:18049 ||| -LRB-
e.g.  ||| S:18049 E:18054 ||| NNP
Brij  ||| S:18054 E:18059 ||| NNP
58 ||| S:18059 E:18061 ||| CD
)  ||| S:18061 E:18063 ||| -RRB-
and  ||| S:18063 E:18067 ||| CC
exclusively  ||| S:18067 E:18079 ||| RB
in  ||| S:18079 E:18092 ||| IN
the  ||| S:18092 E:18096 ||| DT
light  ||| S:18096 E:18102 ||| JJ
membrane  ||| S:18102 E:18111 ||| JJ
fractions  ||| S:18111 E:18121 ||| NNS
of  ||| S:18121 E:18124 ||| IN
a  ||| S:18124 E:18126 ||| DT
sucrose  ||| S:18126 E:18134 ||| JJ
gradient  ||| S:18134 E:18143 ||| NNS
[  ||| S:18143 E:18145 ||| -LRB-
48  ||| S:18145 E:18158 ||| CD
49  ||| S:18158 E:18161 ||| CD
]  ||| S:18161 E:18163 ||| -RRB-
.  ||| S:18163 E:18196 ||| .
Conclusions  ||| S:18196 E:18216 ||| NNS
In  ||| S:18216 E:18219 ||| IN
summary ||| S:18219 E:18226 ||| NN
,  ||| S:18226 E:18228 ||| ,
we  ||| S:18228 E:18231 ||| PRP
show  ||| S:18231 E:18236 ||| VBP
a  ||| S:18236 E:18238 ||| DT
highly  ||| S:18238 E:18245 ||| RB
specific  ||| S:18245 E:18254 ||| JJ
biochemical  ||| S:18254 E:18266 ||| JJ
link  ||| S:18266 E:18279 ||| NN
between  ||| S:18279 E:18287 ||| IN
intact  ||| S:18287 E:18294 ||| JJ
β1  ||| S:18294 E:18297 ||| CD
integrins  ||| S:18297 E:18307 ||| NNS
and  ||| S:18307 E:18311 ||| CC
CD98 ||| S:18311 E:18315 ||| NNP
,  ||| S:18315 E:18317 ||| ,
as  ||| S:18317 E:18320 ||| RB
demonstrated  ||| S:18320 E:18333 ||| VBN
by  ||| S:18333 E:18344 ||| IN
reciprocal  ||| S:18344 E:18355 ||| JJ
co-immunoprecipitation  ||| S:18355 E:18378 ||| JJ
and  ||| S:18378 E:18382 ||| CC
co-clustering  ||| S:18382 E:18404 ||| JJ
experiments ||| S:18404 E:18415 ||| NNS
.  ||| S:18415 E:18417 ||| .
Furthermore ||| S:18417 E:18428 ||| RB
,  ||| S:18428 E:18430 ||| ,
CD98  ||| S:18430 E:18435 ||| CD
association  ||| S:18435 E:18447 ||| NN
with  ||| S:18447 E:18452 ||| IN
β1  ||| S:18452 E:18463 ||| CD
integrins  ||| S:18463 E:18473 ||| NN
appears  ||| S:18473 E:18481 ||| VBZ
to  ||| S:18481 E:18484 ||| TO
occur  ||| S:18484 E:18490 ||| VB
in  ||| S:18490 E:18493 ||| IN
the  ||| S:18493 E:18497 ||| DT
context  ||| S:18497 E:18505 ||| NN
of  ||| S:18505 E:18508 ||| IN
an  ||| S:18508 E:18511 ||| DT
ordered  ||| S:18511 E:18527 ||| VBN
lipid  ||| S:18527 E:18533 ||| JJ
microdomain  ||| S:18533 E:18545 ||| NNS
( ||| S:18545 E:18546 ||| -LRB-
as  ||| S:18546 E:18549 ||| RB
evidenced  ||| S:18549 E:18559 ||| VBN
by  ||| S:18559 E:18562 ||| IN
co-localization  ||| S:18562 E:18578 ||| JJ
in  ||| S:18578 E:18581 ||| IN
light  ||| S:18581 E:18595 ||| JJ
membrane  ||| S:18595 E:18604 ||| JJ
fractions  ||| S:18604 E:18614 ||| NNS
of  ||| S:18614 E:18617 ||| IN
sucrose  ||| S:18617 E:18625 ||| FW
density  ||| S:18625 E:18633 ||| FW
gradients ||| S:18633 E:18642 ||| FW
) ||| S:18642 E:18643 ||| -RRB-
,  ||| S:18643 E:18645 ||| ,
and  ||| S:18645 E:18657 ||| CC
appears  ||| S:18657 E:18665 ||| VBZ
to  ||| S:18665 E:18668 ||| TO
require  ||| S:18668 E:18676 ||| VB
the  ||| S:18676 E:18680 ||| DT
light  ||| S:18680 E:18686 ||| JJ
chain  ||| S:18686 E:18692 ||| NN
of  ||| S:18692 E:18695 ||| IN
CD98 ||| S:18695 E:18699 ||| CD
.  ||| S:18699 E:18701 ||| .
These  ||| S:18701 E:18707 ||| DT
results  ||| S:18707 E:18723 ||| NNS
may  ||| S:18723 E:18727 ||| MD
help  ||| S:18727 E:18732 ||| VB
to  ||| S:18732 E:18735 ||| TO
explain  ||| S:18735 E:18743 ||| VB
recent  ||| S:18743 E:18750 ||| JJ
reports  ||| S:18750 E:18758 ||| NNS
that  ||| S:18758 E:18763 ||| IN
CD98  ||| S:18763 E:18768 ||| NNP
may  ||| S:18768 E:18772 ||| MD
modulate  ||| S:18772 E:18789 ||| VB
integrin  ||| S:18789 E:18798 ||| JJ
ligand  ||| S:18798 E:18805 ||| JJ
binding ||| S:18805 E:18812 ||| NN
,  ||| S:18812 E:18814 ||| ,
adhesion ||| S:18814 E:18822 ||| NN
,  ||| S:18822 E:18824 ||| ,
signaling ||| S:18824 E:18833 ||| VBG
,  ||| S:18833 E:18835 ||| ,
T  ||| S:18835 E:18837 ||| NN
cell  ||| S:18837 E:18850 ||| NN
co-stimulation  ||| S:18850 E:18865 ||| NN
and  ||| S:18865 E:18869 ||| CC
cell  ||| S:18869 E:18874 ||| NN
fusion  ||| S:18874 E:18881 ||| NN
functions ||| S:18881 E:18890 ||| NNS
.  ||| S:18890 E:18914 ||| .
Materials  ||| S:18914 E:18924 ||| NNS
and  ||| S:18924 E:18928 ||| CC
Methods  ||| S:18928 E:18955 ||| NNP
Antibodies ||| S:18955 E:18965 ||| NNP
,  ||| S:18965 E:18967 ||| ,
cell  ||| S:18967 E:18972 ||| NN
lines ||| S:18972 E:18977 ||| NNS
,  ||| S:18977 E:18979 ||| ,
cDNA  ||| S:18979 E:18994 ||| NNP
Monoclonal  ||| S:18994 E:19005 ||| NNP
antibodies  ||| S:19005 E:19016 ||| NNS
used  ||| S:19016 E:19021 ||| VBN
in  ||| S:19021 E:19024 ||| IN
this  ||| S:19024 E:19029 ||| DT
study  ||| S:19029 E:19035 ||| NN
are ||| S:19035 E:19038 ||| VBP
:  ||| S:19038 E:19040 ||| :
4F2 ||| S:19040 E:19043 ||| CD
,  ||| S:19043 E:19055 ||| ,
anti-CD98  ||| S:19055 E:19065 ||| CD
heavy  ||| S:19065 E:19071 ||| JJ
chain  ||| S:19071 E:19077 ||| NN
[  ||| S:19077 E:19079 ||| -LRB-
39  ||| S:19079 E:19082 ||| CD
]  ||| S:19082 E:19084 ||| -RRB-
,  ||| S:19084 E:19086 ||| ,
A2-2E10 ||| S:19086 E:19093 ||| NNP
,  ||| S:19093 E:19095 ||| ,
anti-α2  ||| S:19095 E:19103 ||| CD
integrin  ||| S:19103 E:19122 ||| NNS
[  ||| S:19122 E:19124 ||| -LRB-
32  ||| S:19124 E:19127 ||| CD
]  ||| S:19127 E:19129 ||| -RRB-
;  ||| S:19129 E:19131 ||| :
A3-IIF5 ||| S:19131 E:19138 ||| CD
,  ||| S:19138 E:19140 ||| ,
anti-α3  ||| S:19140 E:19148 ||| CD
integrin  ||| S:19148 E:19157 ||| NNS
[  ||| S:19157 E:19159 ||| -LRB-
50  ||| S:19159 E:19162 ||| CD
]  ||| S:19162 E:19164 ||| -RRB-
;  ||| S:19164 E:19166 ||| :
A5-PUJ2 ||| S:19166 E:19173 ||| CD
,  ||| S:19173 E:19185 ||| ,
anti-α5  ||| S:19185 E:19193 ||| CD
integrin  ||| S:19193 E:19202 ||| NNS
[  ||| S:19202 E:19204 ||| -LRB-
51  ||| S:19204 E:19207 ||| CD
]  ||| S:19207 E:19209 ||| -RRB-
;  ||| S:19209 E:19211 ||| :
B5G10 ||| S:19211 E:19216 ||| CD
,  ||| S:19216 E:19218 ||| ,
anti-α4  ||| S:19218 E:19226 ||| CD
integrin  ||| S:19226 E:19235 ||| NNS
[  ||| S:19235 E:19237 ||| -LRB-
52  ||| S:19237 E:19240 ||| CD
]  ||| S:19240 E:19252 ||| -RRB-
;  ||| S:19252 E:19254 ||| :
A4-PUJ1 ||| S:19254 E:19261 ||| CD
,  ||| S:19261 E:19263 ||| ,
anti-α4  ||| S:19263 E:19271 ||| CD
integrin  ||| S:19271 E:19280 ||| NNS
[  ||| S:19280 E:19282 ||| -LRB-
51  ||| S:19282 E:19285 ||| CD
]  ||| S:19285 E:19287 ||| -RRB-
;  ||| S:19287 E:19289 ||| :
A6-BB ||| S:19289 E:19294 ||| CD
,  ||| S:19294 E:19296 ||| ,
anti-α6  ||| S:19296 E:19314 ||| CD
integrin  ||| S:19314 E:19323 ||| NNS
[  ||| S:19323 E:19325 ||| -LRB-
32  ||| S:19325 E:19328 ||| CD
]  ||| S:19328 E:19330 ||| -RRB-
;  ||| S:19330 E:19332 ||| :
TS2 ||| S:19332 E:19335 ||| CD
/ ||| S:19335 E:19336 ||| CD
16 ||| S:19336 E:19338 ||| CD
,  ||| S:19338 E:19340 ||| ,
anti-β1  ||| S:19340 E:19348 ||| CD
integrin ||| S:19348 E:19356 ||| NNS
;  ||| S:19356 E:19358 ||| :
W6 ||| S:19358 E:19360 ||| CD
/ ||| S:19360 E:19361 ||| CD
32 ||| S:19361 E:19363 ||| CD
,  ||| S:19363 E:19375 ||| ,
anti-HLA  ||| S:19375 E:19384 ||| JJ
class  ||| S:19384 E:19390 ||| NN
I  ||| S:19390 E:19392 ||| PRP
[  ||| S:19392 E:19394 ||| -LRB-
53  ||| S:19394 E:19397 ||| CD
]  ||| S:19397 E:19399 ||| -RRB-
;  ||| S:19399 E:19401 ||| :
C7 ||| S:19401 E:19403 ||| CD
,  ||| S:19403 E:19405 ||| ,
anti-LDL  ||| S:19405 E:19414 ||| JJ
receptor  ||| S:19414 E:19423 ||| NN
[  ||| S:19423 E:19425 ||| -LRB-
54  ||| S:19425 E:19428 ||| CD
]  ||| S:19428 E:19430 ||| -RRB-
;  ||| S:19430 E:19442 ||| :
5E9 ||| S:19442 E:19445 ||| CD
,  ||| S:19445 E:19447 ||| ,
anti-CD71  ||| S:19447 E:19457 ||| NNP
[  ||| S:19457 E:19459 ||| -LRB-
55  ||| S:19459 E:19462 ||| CD
]  ||| S:19462 E:19464 ||| -RRB-
;  ||| S:19464 E:19466 ||| :
IIIC4 ||| S:19466 E:19471 ||| CD
,  ||| S:19471 E:19473 ||| ,
anti-CD  ||| S:19473 E:19481 ||| JJ
109  ||| S:19481 E:19485 ||| CD
[  ||| S:19485 E:19487 ||| -LRB-
32  ||| S:19487 E:19490 ||| CD
]  ||| S:19490 E:19492 ||| -RRB-
;  ||| S:19492 E:19494 ||| :
8G6 ||| S:19494 E:19497 ||| CD
,  ||| S:19497 E:19509 ||| ,
anti-CD147 ||| S:19509 E:19519 ||| NNP
/ ||| S:19519 E:19520 ||| NNP
EMMPRIN  ||| S:19520 E:19528 ||| NNP
[  ||| S:19528 E:19530 ||| -LRB-
31  ||| S:19530 E:19533 ||| CD
]  ||| S:19533 E:19535 ||| -RRB-
;  ||| S:19535 E:19537 ||| :
and  ||| S:19537 E:19541 ||| CC
KMI6 ||| S:19541 E:19545 ||| NNP
,  ||| S:19545 E:19547 ||| ,
anti-mouse  ||| S:19547 E:19558 ||| FW
β1  ||| S:19558 E:19571 ||| FW
integrin  ||| S:19571 E:19580 ||| FW
( ||| S:19580 E:19581 ||| -LRB-
Pharmingen ||| S:19581 E:19591 ||| NNP
,  ||| S:19591 E:19593 ||| ,
San  ||| S:19593 E:19597 ||| NNP
Diego ||| S:19597 E:19602 ||| NNP
,  ||| S:19602 E:19604 ||| ,
CA ||| S:19604 E:19606 ||| NNP
) ||| S:19606 E:19607 ||| -RRB-
.  ||| S:19607 E:19609 ||| .
The  ||| S:19609 E:19613 ||| DT
mAb  ||| S:19613 E:19617 ||| JJ
P3  ||| S:19617 E:19620 ||| NNP
[  ||| S:19620 E:19622 ||| -LRB-
56  ||| S:19622 E:19625 ||| CD
]  ||| S:19625 E:19637 ||| -RRB-
was  ||| S:19637 E:19641 ||| VBD
used  ||| S:19641 E:19646 ||| VBN
in  ||| S:19646 E:19649 ||| IN
all  ||| S:19649 E:19653 ||| DT
immunoprecipitation  ||| S:19653 E:19673 ||| NN
and  ||| S:19673 E:19677 ||| CC
flow  ||| S:19677 E:19682 ||| NN
cytometry  ||| S:19682 E:19702 ||| NN
experiments  ||| S:19702 E:19714 ||| NNS
as  ||| S:19714 E:19717 ||| IN
a  ||| S:19717 E:19719 ||| DT
negative  ||| S:19719 E:19728 ||| JJ
control ||| S:19728 E:19735 ||| NN
.  ||| S:19735 E:19747 ||| .
Human  ||| S:19747 E:19753 ||| JJ
cell  ||| S:19753 E:19758 ||| NN
lines  ||| S:19758 E:19764 ||| NNS
used  ||| S:19764 E:19769 ||| VBN
in  ||| S:19769 E:19772 ||| IN
this  ||| S:19772 E:19777 ||| DT
study  ||| S:19777 E:19783 ||| NN
were  ||| S:19783 E:19788 ||| VBD
the  ||| S:19788 E:19802 ||| DT
fibrosarcoma  ||| S:19802 E:19815 ||| JJ
cell  ||| S:19815 E:19820 ||| NN
line  ||| S:19820 E:19825 ||| NN
HT1080 ||| S:19825 E:19831 ||| NN
;  ||| S:19831 E:19833 ||| :
rhabdomyosarcoma  ||| S:19833 E:19850 ||| JJ
cell  ||| S:19850 E:19855 ||| NN
line  ||| S:19855 E:19870 ||| NN
RD  ||| S:19870 E:19873 ||| NNP
stably  ||| S:19873 E:19880 ||| VBD
transfected  ||| S:19880 E:19892 ||| VBN
with  ||| S:19892 E:19897 ||| IN
human  ||| S:19897 E:19903 ||| JJ
α3  ||| S:19903 E:19906 ||| CD
integrin  ||| S:19906 E:19915 ||| NNS
( ||| S:19915 E:19916 ||| -LRB-
RD  ||| S:19916 E:19919 ||| NNP
A3 ||| S:19919 E:19921 ||| NNP
) ||| S:19921 E:19922 ||| -RRB-
;  ||| S:19922 E:19934 ||| :
lymphoblastoid  ||| S:19934 E:19949 ||| JJ
T  ||| S:19949 E:19951 ||| NN
cell  ||| S:19951 E:19956 ||| NN
line  ||| S:19956 E:19961 ||| NN
Molt4 ||| S:19961 E:19966 ||| NN
,  ||| S:19966 E:19968 ||| ,
human  ||| S:19968 E:19974 ||| JJ
mammary  ||| S:19974 E:19992 ||| JJ
epithelial  ||| S:19992 E:20003 ||| JJ
cell  ||| S:20003 E:20008 ||| NN
line  ||| S:20008 E:20013 ||| NN
MTSV  ||| S:20013 E:20018 ||| NNP
1-7 ||| S:20018 E:20021 ||| NNP
;  ||| S:20021 E:20023 ||| :
erythroleukemia  ||| S:20023 E:20039 ||| CD
K562  ||| S:20039 E:20044 ||| CD
cells  ||| S:20044 E:20060 ||| NNS
and  ||| S:20060 E:20064 ||| CC
φ  ||| S:20064 E:20066 ||| JJ
nx-Eco  ||| S:20066 E:20073 ||| JJ
packaging  ||| S:20073 E:20083 ||| NN
cells ||| S:20083 E:20088 ||| NNS
.  ||| S:20088 E:20090 ||| .
K562  ||| S:20090 E:20095 ||| FW
cells  ||| S:20095 E:20101 ||| FW
expressing  ||| S:20101 E:20122 ||| FW
integrin  ||| S:20122 E:20131 ||| FW
α4 ||| S:20131 E:20133 ||| FW
,  ||| S:20133 E:20135 ||| ,
α3 ||| S:20135 E:20137 ||| NNP
,  ||| S:20137 E:20139 ||| ,
or  ||| S:20139 E:20142 ||| CC
α3  ||| S:20142 E:20145 ||| FW
integrin  ||| S:20145 E:20154 ||| FW
subunit  ||| S:20154 E:20162 ||| FW
lacking  ||| S:20162 E:20170 ||| FW
a  ||| S:20170 E:20182 ||| FW
cytoplasmic  ||| S:20182 E:20194 ||| FW
tail  ||| S:20194 E:20199 ||| FW
( ||| S:20199 E:20200 ||| -LRB-
K562-X3C0 ||| S:20200 E:20209 ||| NNP
)  ||| S:20209 E:20211 ||| -RRB-
were  ||| S:20211 E:20216 ||| VBD
described  ||| S:20216 E:20226 ||| VBN
elsewhere  ||| S:20226 E:20236 ||| RB
[  ||| S:20236 E:20248 ||| -LRB-
30  ||| S:20248 E:20251 ||| CD
40  ||| S:20251 E:20254 ||| CD
]  ||| S:20254 E:20256 ||| -RRB-
.  ||| S:20256 E:20258 ||| .
Also  ||| S:20258 E:20263 ||| RB
utilized  ||| S:20263 E:20272 ||| RB
were  ||| S:20272 E:20277 ||| VBD
K562  ||| S:20277 E:20282 ||| CD
cells  ||| S:20282 E:20288 ||| NNS
expressing  ||| S:20288 E:20299 ||| VBG
α3  ||| S:20299 E:20312 ||| CD
D154A ||| S:20312 E:20317 ||| CD
,  ||| S:20317 E:20319 ||| ,
W220A  ||| S:20319 E:20325 ||| NNP
and  ||| S:20325 E:20329 ||| CC
Y218A  ||| S:20329 E:20335 ||| CD
mutants  ||| S:20335 E:20343 ||| NNS
[  ||| S:20343 E:20345 ||| -LRB-
41  ||| S:20345 E:20348 ||| CD
]  ||| S:20348 E:20350 ||| -RRB-
,  ||| S:20350 E:20352 ||| ,
and  ||| S:20352 E:20356 ||| CC
Chinese  ||| S:20356 E:20374 ||| JJ
hamster  ||| S:20374 E:20382 ||| JJ
ovary  ||| S:20382 E:20388 ||| NNS
( ||| S:20388 E:20389 ||| -LRB-
CHO ||| S:20389 E:20392 ||| NNP
)  ||| S:20392 E:20394 ||| -RRB-
cells  ||| S:20394 E:20400 ||| NNS
that  ||| S:20400 E:20405 ||| WDT
express  ||| S:20405 E:20413 ||| VBP
human  ||| S:20413 E:20419 ||| JJ
α2 ||| S:20419 E:20421 ||| NN
,  ||| S:20421 E:20423 ||| ,
α3 ||| S:20423 E:20425 ||| NNP
,  ||| S:20425 E:20427 ||| ,
α5  ||| S:20427 E:20440 ||| NNP
or  ||| S:20440 E:20443 ||| CC
β1  ||| S:20443 E:20446 ||| FW
integrin  ||| S:20446 E:20455 ||| FW
subunits  ||| S:20455 E:20464 ||| FW
[  ||| S:20464 E:20466 ||| -LRB-
30  ||| S:20466 E:20469 ||| CD
32  ||| S:20469 E:20472 ||| CD
]  ||| S:20472 E:20474 ||| -RRB-
.  ||| S:20474 E:20476 ||| .
The  ||| S:20476 E:20480 ||| DT
cDNA  ||| S:20480 E:20485 ||| JJ
encoding  ||| S:20485 E:20504 ||| JJ
human  ||| S:20504 E:20510 ||| JJ
CD98  ||| S:20510 E:20515 ||| CD
heavy  ||| S:20515 E:20521 ||| JJ
chain  ||| S:20521 E:20527 ||| NN
[  ||| S:20527 E:20529 ||| -LRB-
57  ||| S:20529 E:20532 ||| CD
]  ||| S:20532 E:20534 ||| -RRB-
was  ||| S:20534 E:20538 ||| VBD
provided  ||| S:20538 E:20547 ||| VBN
by  ||| S:20547 E:20550 ||| IN
Jeffrey  ||| S:20550 E:20568 ||| NNP
Leiden  ||| S:20568 E:20575 ||| NNP
( ||| S:20575 E:20576 ||| -LRB-
University  ||| S:20576 E:20587 ||| NNP
of  ||| S:20587 E:20590 ||| IN
Chicago ||| S:20590 E:20597 ||| NNP
)  ||| S:20597 E:20599 ||| -RRB-
in  ||| S:20599 E:20602 ||| IN
the  ||| S:20602 E:20606 ||| DT
pUC18  ||| S:20606 E:20612 ||| JJ
vector ||| S:20612 E:20618 ||| NN
.  ||| S:20618 E:20620 ||| .
CD98  ||| S:20620 E:20635 ||| NNP
heavy  ||| S:20635 E:20641 ||| JJ
chain  ||| S:20641 E:20647 ||| NN
mutants  ||| S:20647 E:20655 ||| NNS
( ||| S:20655 E:20656 ||| -LRB-
C109S  ||| S:20656 E:20662 ||| NNP
and  ||| S:20662 E:20666 ||| CC
C330S ||| S:20666 E:20671 ||| CD
)  ||| S:20671 E:20673 ||| -RRB-
were  ||| S:20673 E:20678 ||| VBD
made  ||| S:20678 E:20683 ||| VBN
by  ||| S:20683 E:20696 ||| IN
recombinant  ||| S:20696 E:20708 ||| JJ
PCR  ||| S:20708 E:20712 ||| NNP
technique  ||| S:20712 E:20722 ||| NN
[  ||| S:20722 E:20724 ||| -LRB-
58  ||| S:20724 E:20727 ||| CD
]  ||| S:20727 E:20729 ||| -RRB-
with  ||| S:20729 E:20734 ||| IN
the  ||| S:20734 E:20738 ||| DT
following  ||| S:20738 E:20758 ||| JJ
primers ||| S:20758 E:20765 ||| NN
:  ||| S:20765 E:20767 ||| :
C109Ss  ||| S:20767 E:20774 ||| CD
-  ||| S:20774 E:20776 ||| :
5 ||| S:20776 E:20777 ||| CD
' ||| S:20777 E:20778 ||| POS
-CGAGCGCCGCGTTCTCGCGAGCTACCGGCG-3 ||| S:20778 E:20811 ||| NNP
' ||| S:20811 E:20812 ||| POS
;  ||| S:20812 E:20824 ||| :
C109Sas-5 ||| S:20824 E:20833 ||| NNP
' ||| S:20833 E:20834 ||| POS
-CGCCGGTAGCTCGCGAGAACGCGGCGCTCG-3 ||| S:20834 E:20867 ||| NNP
' ||| S:20867 E:20868 ||| POS
;  ||| S:20868 E:20870 ||| :
C330Ss  ||| S:20870 E:20877 ||| CD
-  ||| S:20877 E:20889 ||| :
5 ||| S:20889 E:20890 ||| CD
' ||| S:20890 E:20891 ||| POS
-GGCAATCGCTGGTCCAGCTGGAGTTTGTCTCAGGC-3 ||| S:20891 E:20929 ||| NNP
' ||| S:20929 E:20930 ||| POS
; ||| S:20930 E:20931 ||| :
C330Sas  ||| S:20931 E:20939 ||| CD
-  ||| S:20939 E:20951 ||| :
5 ||| S:20951 E:20952 ||| CD
' ||| S:20952 E:20953 ||| POS
-GCCTGAGACAAACTCCAGCTGGACCAGCGATTGCC-3 ||| S:20953 E:20991 ||| NNP
' ||| S:20991 E:20992 ||| POS
.  ||| S:20992 E:20994 ||| .
CD98  ||| S:20994 E:20999 ||| NNP
heavy  ||| S:20999 E:21015 ||| JJ
chain  ||| S:21015 E:21021 ||| NN
constructs  ||| S:21021 E:21032 ||| NNS
were  ||| S:21032 E:21037 ||| VBD
subcloned  ||| S:21037 E:21047 ||| VBN
into  ||| S:21047 E:21052 ||| IN
pLXIZ  ||| S:21052 E:21058 ||| JJ
retroviral  ||| S:21058 E:21079 ||| JJ
vector  ||| S:21079 E:21086 ||| NN
( ||| S:21086 E:21087 ||| -LRB-
Clontech ||| S:21087 E:21095 ||| NNP
) ||| S:21095 E:21096 ||| -RRB-
.  ||| S:21096 E:21098 ||| .
Transient  ||| S:21098 E:21108 ||| JJ
transfection  ||| S:21108 E:21121 ||| NN
of  ||| S:21121 E:21124 ||| IN
φ  ||| S:21124 E:21126 ||| JJ
nx-Eco  ||| S:21126 E:21143 ||| JJ
cells  ||| S:21143 E:21149 ||| NNS
and  ||| S:21149 E:21153 ||| CC
retroviral  ||| S:21153 E:21164 ||| JJ
infection  ||| S:21164 E:21174 ||| NN
of  ||| S:21174 E:21177 ||| IN
NIH  ||| S:21177 E:21181 ||| NNP
3T3  ||| S:21181 E:21185 ||| NNP
cells  ||| S:21185 E:21191 ||| NNS
was  ||| S:21191 E:21205 ||| VBD
performed  ||| S:21205 E:21215 ||| VBN
as  ||| S:21215 E:21218 ||| RB
described  ||| S:21218 E:21228 ||| VBN
[  ||| S:21228 E:21230 ||| -LRB-
59  ||| S:21230 E:21233 ||| CD
]  ||| S:21233 E:21235 ||| -RRB-
.  ||| S:21235 E:21237 ||| .
Stable  ||| S:21237 E:21244 ||| JJ
NIH  ||| S:21244 E:21248 ||| NNP
3T3  ||| S:21248 E:21252 ||| NNP
infectants  ||| S:21252 E:21273 ||| NN
were  ||| S:21273 E:21278 ||| VBD
selected  ||| S:21278 E:21287 ||| VBN
in  ||| S:21287 E:21290 ||| IN
growth  ||| S:21290 E:21297 ||| NN
medium  ||| S:21297 E:21304 ||| NN
containing  ||| S:21304 E:21315 ||| VBG
1  ||| S:21315 E:21317 ||| CD
mg ||| S:21317 E:21319 ||| CD
/ ||| S:21319 E:21320 ||| CD
ml  ||| S:21320 E:21333 ||| CD
zeocin ||| S:21333 E:21339 ||| NNS
.  ||| S:21339 E:21369 ||| .
Immunoprecipitation  ||| S:21369 E:21389 ||| JJ
experiments  ||| S:21389 E:21411 ||| NNS
For  ||| S:21411 E:21415 ||| IN
immunoprecipitations ||| S:21415 E:21435 ||| NN
,  ||| S:21435 E:21437 ||| ,
labeled  ||| S:21437 E:21445 ||| VBN
cellular  ||| S:21445 E:21454 ||| JJ
proteins  ||| S:21454 E:21473 ||| NNS
were  ||| S:21473 E:21478 ||| VBD
extracted  ||| S:21478 E:21488 ||| VBN
with  ||| S:21488 E:21493 ||| IN
lysis  ||| S:21493 E:21499 ||| JJ
buffer  ||| S:21499 E:21506 ||| NN
( ||| S:21506 E:21507 ||| -LRB-
1 ||| S:21507 E:21508 ||| CD
%  ||| S:21508 E:21510 ||| NN
of  ||| S:21510 E:21513 ||| IN
the  ||| S:21513 E:21517 ||| DT
indicated  ||| S:21517 E:21537 ||| JJ
detergent ||| S:21537 E:21546 ||| NN
,  ||| S:21546 E:21548 ||| ,
20  ||| S:21548 E:21551 ||| CD
mM  ||| S:21551 E:21554 ||| JJ
Hepes ||| S:21554 E:21559 ||| NNP
,  ||| S:21559 E:21561 ||| ,
pH  ||| S:21561 E:21564 ||| JJ
7.4 ||| S:21564 E:21567 ||| CD
,  ||| S:21567 E:21569 ||| ,
150  ||| S:21569 E:21573 ||| CD
mM  ||| S:21573 E:21576 ||| JJ
NaCl ||| S:21576 E:21580 ||| NN
,  ||| S:21580 E:21582 ||| ,
2  ||| S:21582 E:21584 ||| CD
mM  ||| S:21584 E:21587 ||| JJ
PMSF ||| S:21587 E:21591 ||| NNP
,  ||| S:21591 E:21603 ||| ,
10  ||| S:21603 E:21606 ||| CD
μg ||| S:21606 E:21608 ||| CD
/ ||| S:21608 E:21609 ||| CD
ml  ||| S:21609 E:21612 ||| JJ
leupeptin ||| S:21612 E:21621 ||| NN
,  ||| S:21621 E:21623 ||| ,
10  ||| S:21623 E:21626 ||| CD
μg ||| S:21626 E:21628 ||| CD
/ ||| S:21628 E:21629 ||| CD
ml  ||| S:21629 E:21632 ||| JJ
aprotinin ||| S:21632 E:21641 ||| NN
,  ||| S:21641 E:21643 ||| ,
2  ||| S:21643 E:21645 ||| CD
mM  ||| S:21645 E:21648 ||| JJ
MgCl2 ||| S:21648 E:21653 ||| NN
,  ||| S:21653 E:21655 ||| ,
0.5  ||| S:21655 E:21669 ||| CD
mM  ||| S:21669 E:21672 ||| JJ
CaCl2 ||| S:21672 E:21677 ||| CD
)  ||| S:21677 E:21679 ||| -RRB-
for  ||| S:21679 E:21683 ||| IN
60  ||| S:21683 E:21686 ||| CD
minutes  ||| S:21686 E:21694 ||| NNS
at  ||| S:21694 E:21697 ||| IN
4°C ||| S:21697 E:21700 ||| CD
.  ||| S:21700 E:21702 ||| .
After  ||| S:21702 E:21708 ||| IN
preincubation  ||| S:21708 E:21722 ||| NN
with  ||| S:21722 E:21737 ||| IN
protein  ||| S:21737 E:21745 ||| JJ
A-sepharose  ||| S:21745 E:21757 ||| JJ
4CL ||| S:21757 E:21760 ||| NN
,  ||| S:21760 E:21762 ||| ,
the  ||| S:21762 E:21766 ||| DT
cell  ||| S:21766 E:21771 ||| NN
extract  ||| S:21771 E:21779 ||| NN
was  ||| S:21779 E:21783 ||| VBD
incubated  ||| S:21783 E:21803 ||| VBN
with  ||| S:21803 E:21808 ||| IN
specific  ||| S:21808 E:21817 ||| JJ
mAb  ||| S:21817 E:21821 ||| NN
directly  ||| S:21821 E:21830 ||| RB
conjugated  ||| S:21830 E:21841 ||| VBN
to  ||| S:21841 E:21844 ||| TO
sepharose  ||| S:21844 E:21854 ||| CD
4B  ||| S:21854 E:21857 ||| CD
for  ||| S:21857 E:21871 ||| IN
60  ||| S:21871 E:21874 ||| CD
min ||| S:21874 E:21877 ||| NN
,  ||| S:21877 E:21879 ||| ,
washed  ||| S:21879 E:21886 ||| VBD
3  ||| S:21886 E:21888 ||| CD
times  ||| S:21888 E:21894 ||| NNS
with  ||| S:21894 E:21899 ||| IN
the  ||| S:21899 E:21903 ||| DT
appropriate  ||| S:21903 E:21915 ||| JJ
lysis  ||| S:21915 E:21921 ||| JJ
buffer  ||| S:21921 E:21938 ||| NN
and  ||| S:21938 E:21942 ||| CC
eluted  ||| S:21942 E:21949 ||| NN
with  ||| S:21949 E:21954 ||| IN
Laemmli  ||| S:21954 E:21962 ||| NNP
sample  ||| S:21962 E:21969 ||| NN
buffer ||| S:21969 E:21975 ||| NN
.  ||| S:21975 E:21977 ||| .
In  ||| S:21977 E:21980 ||| IN
some  ||| S:21980 E:21995 ||| DT
experiments  ||| S:21995 E:22007 ||| NNS
manganese  ||| S:22007 E:22017 ||| JJ
chloride  ||| S:22017 E:22026 ||| NN
( ||| S:22026 E:22027 ||| -LRB-
2  ||| S:22027 E:22029 ||| CD
mM ||| S:22029 E:22031 ||| NN
)  ||| S:22031 E:22033 ||| -RRB-
was  ||| S:22033 E:22037 ||| VBD
added  ||| S:22037 E:22043 ||| VBN
both  ||| S:22043 E:22048 ||| CC
to  ||| S:22048 E:22061 ||| TO
cells  ||| S:22061 E:22067 ||| NNS
( ||| S:22067 E:22068 ||| -LRB-
10  ||| S:22068 E:22071 ||| CD
minutes  ||| S:22071 E:22079 ||| NNS
prior  ||| S:22079 E:22085 ||| RB
to  ||| S:22085 E:22088 ||| TO
lysis ||| S:22088 E:22093 ||| CD
)  ||| S:22093 E:22095 ||| -RRB-
and  ||| S:22095 E:22099 ||| CC
to  ||| S:22099 E:22102 ||| TO
the  ||| S:22102 E:22106 ||| DT
lysis  ||| S:22106 E:22122 ||| JJ
buffer ||| S:22122 E:22128 ||| NN
.  ||| S:22128 E:22140 ||| .
For  ||| S:22140 E:22144 ||| IN
re-immunoprecipitation  ||| S:22144 E:22167 ||| JJ
experiments ||| S:22167 E:22178 ||| NNS
,  ||| S:22178 E:22180 ||| ,
associated  ||| S:22180 E:22201 ||| VBN
proteins  ||| S:22201 E:22210 ||| NNS
were  ||| S:22210 E:22215 ||| VBD
eluted  ||| S:22215 E:22222 ||| VBN
from  ||| S:22222 E:22227 ||| IN
immune  ||| S:22227 E:22234 ||| JJ
complexes  ||| S:22234 E:22244 ||| NNS
in  ||| S:22244 E:22247 ||| IN
1 ||| S:22247 E:22248 ||| CD
%  ||| S:22248 E:22250 ||| NN
Triton  ||| S:22250 E:22267 ||| NNP
X100  ||| S:22267 E:22272 ||| NNP
in  ||| S:22272 E:22275 ||| IN
PBS ||| S:22275 E:22278 ||| NNP
,  ||| S:22278 E:22280 ||| ,
then  ||| S:22280 E:22285 ||| RB
pre-incubated  ||| S:22285 E:22299 ||| JJ
with  ||| S:22299 E:22304 ||| IN
protein  ||| S:22304 E:22322 ||| NN
A-sepharose-4CL ||| S:22322 E:22337 ||| NN
.  ||| S:22337 E:22339 ||| .
Remaining  ||| S:22339 E:22349 ||| VBG
proteins  ||| S:22349 E:22358 ||| NNS
were  ||| S:22358 E:22363 ||| VBD
then  ||| S:22363 E:22378 ||| RB
re-precipitated  ||| S:22378 E:22394 ||| JJ
from  ||| S:22394 E:22399 ||| IN
the  ||| S:22399 E:22403 ||| DT
eluate  ||| S:22403 E:22410 ||| NN
using  ||| S:22410 E:22416 ||| VBG
mAb  ||| S:22416 E:22420 ||| JJ
directly  ||| S:22420 E:22439 ||| RB
conjugated  ||| S:22439 E:22450 ||| VBN
to  ||| S:22450 E:22453 ||| TO
sepharose  ||| S:22453 E:22463 ||| CD
4B  ||| S:22463 E:22466 ||| CD
beads  ||| S:22466 E:22472 ||| NN
for  ||| S:22472 E:22476 ||| IN
30  ||| S:22476 E:22479 ||| CD
min  ||| S:22479 E:22483 ||| NN
at  ||| S:22483 E:22486 ||| IN
4°C ||| S:22486 E:22489 ||| NNP
,  ||| S:22489 E:22501 ||| ,
washed  ||| S:22501 E:22508 ||| VBD
three  ||| S:22508 E:22514 ||| CD
times  ||| S:22514 E:22520 ||| NNS
with  ||| S:22520 E:22525 ||| IN
1 ||| S:22525 E:22526 ||| CD
%  ||| S:22526 E:22528 ||| NN
Triton  ||| S:22528 E:22535 ||| NNP
X100  ||| S:22535 E:22540 ||| NNP
in  ||| S:22540 E:22543 ||| IN
PBS ||| S:22543 E:22546 ||| NNP
,  ||| S:22546 E:22548 ||| ,
eluted  ||| S:22548 E:22565 ||| VBG
with  ||| S:22565 E:22570 ||| IN
Laemmli  ||| S:22570 E:22578 ||| NNP
sample  ||| S:22578 E:22585 ||| NN
buffer ||| S:22585 E:22591 ||| NN
,  ||| S:22591 E:22593 ||| ,
and  ||| S:22593 E:22597 ||| CC
resolved  ||| S:22597 E:22606 ||| VBN
on  ||| S:22606 E:22609 ||| IN
SDS-PAGE ||| S:22609 E:22617 ||| JJ
.  ||| S:22617 E:22647 ||| .
Detergent-free  ||| S:22647 E:22662 ||| JJ
purification  ||| S:22662 E:22675 ||| NN
of  ||| S:22675 E:22678 ||| IN
light  ||| S:22678 E:22684 ||| JJ
membrane  ||| S:22684 E:22703 ||| FW
fractions  ||| S:22703 E:22723 ||| FW
Isopycnic  ||| S:22723 E:22733 ||| FW
fractionation  ||| S:22733 E:22747 ||| FW
in  ||| S:22747 E:22750 ||| IN
sucrose  ||| S:22750 E:22758 ||| JJ
gradients  ||| S:22758 E:22768 ||| NN
was  ||| S:22768 E:22782 ||| VBD
performed  ||| S:22782 E:22792 ||| VBN
essentially  ||| S:22792 E:22804 ||| RB
as  ||| S:22804 E:22807 ||| RB
described  ||| S:22807 E:22817 ||| VBN
[  ||| S:22817 E:22819 ||| -LRB-
43  ||| S:22819 E:22822 ||| CD
]  ||| S:22822 E:22824 ||| -RRB-
.  ||| S:22824 E:22826 ||| .
Briefly ||| S:22826 E:22833 ||| RB
,  ||| S:22833 E:22845 ||| ,
cells  ||| S:22845 E:22851 ||| NNS
( ||| S:22851 E:22852 ||| -LRB-
one  ||| S:22852 E:22856 ||| CD
confluent  ||| S:22856 E:22866 ||| CD
T162  ||| S:22866 E:22871 ||| CD
flask  ||| S:22871 E:22877 ||| NN
of  ||| S:22877 E:22880 ||| IN
HT1080  ||| S:22880 E:22887 ||| NNP
or  ||| S:22887 E:22890 ||| CC
NIH  ||| S:22890 E:22894 ||| NNP
3T3  ||| S:22894 E:22908 ||| NNP
cells  ||| S:22908 E:22914 ||| NNS
expressing  ||| S:22914 E:22925 ||| VBG
different  ||| S:22925 E:22935 ||| JJ
CD98  ||| S:22935 E:22940 ||| CD
constructs ||| S:22940 E:22950 ||| CD
)  ||| S:22950 E:22952 ||| -RRB-
were  ||| S:22952 E:22957 ||| VBD
lysed  ||| S:22957 E:22963 ||| VBN
in  ||| S:22963 E:22976 ||| IN
2  ||| S:22976 E:22978 ||| CD
ml  ||| S:22978 E:22981 ||| CD
500  ||| S:22981 E:22985 ||| CD
mM  ||| S:22985 E:22988 ||| JJ
sodium  ||| S:22988 E:22995 ||| JJ
carbonate  ||| S:22995 E:23005 ||| JJ
buffer ||| S:23005 E:23011 ||| NN
,  ||| S:23011 E:23013 ||| ,
pH  ||| S:23013 E:23016 ||| JJ
11 ||| S:23016 E:23018 ||| CD
,  ||| S:23018 E:23020 ||| ,
in  ||| S:23020 E:23023 ||| IN
the  ||| S:23023 E:23037 ||| DT
presence  ||| S:23037 E:23046 ||| NN
of  ||| S:23046 E:23049 ||| IN
protease  ||| S:23049 E:23058 ||| JJ
inhibitors  ||| S:23058 E:23069 ||| NN
and  ||| S:23069 E:23073 ||| CC
passed  ||| S:23073 E:23080 ||| VBN
through  ||| S:23080 E:23088 ||| IN
25  ||| S:23088 E:23101 ||| CD
gauge  ||| S:23101 E:23107 ||| CD
needle  ||| S:23107 E:23114 ||| CD
5  ||| S:23114 E:23116 ||| CD
times  ||| S:23116 E:23122 ||| NNS
followed  ||| S:23122 E:23131 ||| VBN
by  ||| S:23131 E:23134 ||| IN
6  ||| S:23134 E:23136 ||| CD
passages  ||| S:23136 E:23145 ||| NNS
through  ||| S:23145 E:23153 ||| IN
27  ||| S:23153 E:23166 ||| CD
gauge  ||| S:23166 E:23172 ||| NN
needle ||| S:23172 E:23178 ||| NN
.  ||| S:23178 E:23180 ||| .
The  ||| S:23180 E:23184 ||| DT
homogenate  ||| S:23184 E:23195 ||| NN
( ||| S:23195 E:23196 ||| -LRB-
1  ||| S:23196 E:23198 ||| CD
ml ||| S:23198 E:23200 ||| CD
)  ||| S:23200 E:23202 ||| -RRB-
was  ||| S:23202 E:23206 ||| VBD
adjusted  ||| S:23206 E:23215 ||| VBN
to  ||| S:23215 E:23218 ||| TO
45 ||| S:23218 E:23220 ||| CD
%  ||| S:23220 E:23232 ||| NN
sucrose  ||| S:23232 E:23240 ||| NN
by  ||| S:23240 E:23243 ||| IN
addition  ||| S:23243 E:23252 ||| NN
of  ||| S:23252 E:23255 ||| IN
1  ||| S:23255 E:23257 ||| CD
ml  ||| S:23257 E:23260 ||| NN
of  ||| S:23260 E:23263 ||| IN
90 ||| S:23263 E:23265 ||| CD
%  ||| S:23265 E:23267 ||| NN
sucrose  ||| S:23267 E:23275 ||| NN
in  ||| S:23275 E:23278 ||| IN
MBS  ||| S:23278 E:23282 ||| NNP
( ||| S:23282 E:23283 ||| -LRB-
25  ||| S:23283 E:23286 ||| CD
mM  ||| S:23286 E:23299 ||| JJ
MES ||| S:23299 E:23302 ||| NNP
,  ||| S:23302 E:23304 ||| ,
pH6.5 ||| S:23304 E:23309 ||| NNP
,  ||| S:23309 E:23311 ||| ,
150  ||| S:23311 E:23315 ||| CD
mM  ||| S:23315 E:23318 ||| JJ
NaCl ||| S:23318 E:23322 ||| NN
)  ||| S:23322 E:23324 ||| -RRB-
and  ||| S:23324 E:23328 ||| CC
placed  ||| S:23328 E:23335 ||| VBN
at  ||| S:23335 E:23338 ||| IN
the  ||| S:23338 E:23342 ||| DT
bottom  ||| S:23342 E:23349 ||| NN
of  ||| S:23349 E:23352 ||| IN
an  ||| S:23352 E:23365 ||| DT
ultracentrifuge  ||| S:23365 E:23381 ||| JJ
tube ||| S:23381 E:23385 ||| NN
.  ||| S:23385 E:23387 ||| .
A  ||| S:23387 E:23389 ||| DT
5-35 ||| S:23389 E:23393 ||| JJ
%  ||| S:23393 E:23395 ||| NN
discontinuous  ||| S:23395 E:23409 ||| VBZ
sucrose  ||| S:23409 E:23427 ||| JJ
gradient  ||| S:23427 E:23436 ||| NN
was  ||| S:23436 E:23440 ||| VBD
formed  ||| S:23440 E:23447 ||| VBN
above  ||| S:23447 E:23453 ||| IN
( ||| S:23453 E:23454 ||| -LRB-
1  ||| S:23454 E:23456 ||| CD
ml  ||| S:23456 E:23459 ||| NN
of  ||| S:23459 E:23462 ||| IN
5 ||| S:23462 E:23463 ||| CD
%  ||| S:23463 E:23465 ||| NN
sucrose ||| S:23465 E:23472 ||| NNS
:  ||| S:23472 E:23474 ||| :
2  ||| S:23474 E:23476 ||| CD
ml  ||| S:23476 E:23479 ||| NN
of  ||| S:23479 E:23492 ||| IN
35 ||| S:23492 E:23494 ||| CD
%  ||| S:23494 E:23496 ||| NN
sucrose ||| S:23496 E:23503 ||| NN
,  ||| S:23503 E:23505 ||| ,
both  ||| S:23505 E:23510 ||| DT
in  ||| S:23510 E:23513 ||| IN
MBS  ||| S:23513 E:23517 ||| NNP
containing  ||| S:23517 E:23528 ||| VBG
250  ||| S:23528 E:23532 ||| CD
mM  ||| S:23532 E:23535 ||| JJ
sodium  ||| S:23535 E:23552 ||| JJ
carbonate ||| S:23552 E:23561 ||| NN
)  ||| S:23561 E:23563 ||| -RRB-
and  ||| S:23563 E:23567 ||| CC
centrifuged  ||| S:23567 E:23579 ||| NN
at  ||| S:23579 E:23582 ||| IN
45  ||| S:23582 E:23585 ||| CD
000  ||| S:23585 E:23589 ||| CD
rpm  ||| S:23589 E:23593 ||| NN
for  ||| S:23593 E:23597 ||| IN
16-18  ||| S:23597 E:23603 ||| CD
hrs  ||| S:23603 E:23607 ||| NN
in  ||| S:23607 E:23620 ||| IN
SW  ||| S:23620 E:23623 ||| NNP
55  ||| S:23623 E:23626 ||| CD
Ti  ||| S:23626 E:23629 ||| JJ
rotor  ||| S:23629 E:23635 ||| NNS
( ||| S:23635 E:23636 ||| -LRB-
Beckman  ||| S:23636 E:23644 ||| NNP
Instruments ||| S:23644 E:23655 ||| NNP
,  ||| S:23655 E:23657 ||| ,
Palo  ||| S:23657 E:23662 ||| NNP
Alto ||| S:23662 E:23666 ||| NNP
,  ||| S:23666 E:23668 ||| ,
CA ||| S:23668 E:23670 ||| NNP
) ||| S:23670 E:23671 ||| -RRB-
.  ||| S:23671 E:23673 ||| .
From  ||| S:23673 E:23688 ||| IN
the  ||| S:23688 E:23692 ||| DT
top  ||| S:23692 E:23696 ||| NN
of  ||| S:23696 E:23699 ||| IN
each  ||| S:23699 E:23704 ||| DT
gradient  ||| S:23704 E:23713 ||| JJ
0.4  ||| S:23713 E:23717 ||| CD
ml  ||| S:23717 E:23720 ||| CD
fractions  ||| S:23720 E:23730 ||| NNS
were  ||| S:23730 E:23735 ||| VBD
collected  ||| S:23735 E:23755 ||| VBN
and  ||| S:23755 E:23759 ||| CC
analyzed  ||| S:23759 E:23768 ||| VBD
by  ||| S:23768 E:23771 ||| IN
SDS-PAGE  ||| S:23771 E:23780 ||| JJ
electrophoresis ||| S:23780 E:23795 ||| NN
,  ||| S:23795 E:23797 ||| ,
or  ||| S:23797 E:23800 ||| CC
adjusted  ||| S:23800 E:23809 ||| VBN
to  ||| S:23809 E:23822 ||| TO
pH  ||| S:23822 E:23825 ||| JJ
7.5  ||| S:23825 E:23829 ||| CD
( ||| S:23829 E:23830 ||| -LRB-
with  ||| S:23830 E:23835 ||| IN
HCl ||| S:23835 E:23838 ||| NNP
)  ||| S:23838 E:23840 ||| -RRB-
and  ||| S:23840 E:23844 ||| CC
used  ||| S:23844 E:23849 ||| VBN
for  ||| S:23849 E:23853 ||| IN
immunoprecipitation  ||| S:23853 E:23883 ||| JJ
experiments ||| S:23883 E:23894 ||| NNS
.  ||| S:23894 E:23920 ||| .
